Upload
others
View
15
Download
0
Embed Size (px)
Citation preview
2
TABLE OF CONTENTS
1. RESEARCH INTERESTS 3
2. ACTIVE RESEARCH PROJECTS 3
3. ACTIVE HDR STUDENT RESEARCH PROJECTS 3
4. RESEARCH (GRADUATES COMPLETED) 4
5. ACADEMIC QUALIFICATIONS, MEMBERSHIPS AND AWARDS 5
6. POSITIONS HELD 6
7. OTHER EXPERIENCE 6
8. SERVICE 7
9. PUBLICATIONS 9
10. RESEARCH GRANTS SUMMARY UPDATED TO 2013 21
11. RESEARCH SUPPORT - FUNDS AND SOURCE UPDATED TO 2013 21
12. RESEARCH GRANTS PRIOR TO 1992 23
13. SCIENTIFIC COMMUNICATIONS 26
14. INVITED PRESENTATIONS – PROFESSIONAL CONFERENCES 37
15. CONTINUING EDUCATION ARTICLES IN PROFESSIONAL
JOURNALS 42
3
NAME: SHALOM ISAAC BENRIMOJ
EMAIL: [email protected]
MARITAL STATUS: Married with two children
CITIZENSHIP: Australian, United Kingdom
1. RESEARCH INTERESTS My research interests encompass the future of community pharmacy and the delivery of professional
cognitive pharmaceutical services from community pharmacy, current and emergent national and
international health services. Specific research programs evaluate the pharmaco-epidemiological, clinical,
pharmaco-economic, standards for delivery, and implementation aspects of services.
These include the provision of:
Drug information to consumers and other health care providers,
Clinical interventions,
Patient medication reviews,
Disease state management systems,
Participation in therapeutics decision systems,
Pharmacy and Pharmacist only medications,
Changing management in community pharmacy,
Implementation of Cognitive Pharmaceutical Services
2. ACTIVE RESEARCH PROJECTS
“Programa Consigue”: The Clinical, Economic and Humanistic impact of Medication review
with follow up (SFT) on elderly patients with poly-pharmacy (University of Granada, Spain)
UTS Pharmacy Barometer (University of Technology Sydney, Australia)
Development, Evaluation and Implementation of a community pharmacy service for patients at
cardiovascular risk (University of Technology Sydney, Australia, D. Sabater Hernandez)
Adherence Service Implementation Program: AIM_HIGH (University of Technology Sydney,
Australia)
Pharmaceutical Services Model for Suitable Delivery of Asthma Services (University of
Technology Sydney, Australia, J. Fuller)
An Australian Minor Ailment Health Scheme (University of Technology Sydney, Australia)
Smoking Cessation Services from Community Pharmacies: A Collaborative Approach (University
of Technology Sydney, Australia)
3. ACTIVE HIGHER DEGREE RESEARCH STUDENT PROJECTS
Facilitation models for implementing professional services in community pharmacies
(University of Granada, Spain, B. Perez Escamilla Ph.D.)
Professional collaboration between community pharmacists and medical practitioners
(University of Granada, Spain, A. Sanchez Molina Ph.D.)
Business factors for implementation services (University of Granada, Spain, A. Noain
Ph.D.)
Pharmacist and patient interactions (University of Granada, Spain, M. Sabater Galindo
Ph.D.)
Economic Impact of medication reviews with Follow Up (University of Basque
Country, Spain, A. Malet Larrea Ph.D.)
Implementation of Cognitive Pharmaceutical services (University of Technology
Sydney, Australia, J. Moullin Ph.D.)
4
Analysis of Community pharmacy services on asthma outcomes (University of
Granada, Spain, C. Crespo Gonzalez)
Program for the implementation of a medication adherence service in a community
pharmacy setting (University of Technology Sydney, Australia, R. Cutler Ph.D.)
Financial analysis of an adherence service from a community pharmacy perspective
(University of Technology Sydney, Australia, S. Zeater Ph.D.)
Minor Ailment care in Australia (University of Technology, Australia, M. Aly)
Optimizing pharmaceutical services in the community pharmacy setting (University of
Granada, Spain, L. Franco Trigo)
Developing and piloting a service for patients at cardiovascular risk in the community
pharmacy setting (University of Technology, Australia, D. Durks)
Preliminary context analysis for exploring the conditions that can influence the
development of services in the community pharmacy (University of Technology
Sydney, Australia, L. Hossain)
4. RESEARCH (GRADUATES COMPLETED)
4.1 Ph.D.
Pharmaceutical services for patients undergoing Haemodialysis. (T. Salgado 2012).
Clinical Impact of medication review with follow up on elderly patients with poly-pharmacy (L.
Sáez-Benito 2012).
Effect of a pharmacist intervention on asthma control. The AFasma Study (M. Garcia Cardenas
2012).
Building capacity in community pharmacies to implement services (E. Feletto 2010).
An inter-disciplinary CQI approach to improving health using community QUM indicators (L.I.
Emerson 2006).
Pharmaceutical services from NSW private hospitals (R. Moles 2006).
Facilities and barriers for the dissemination and implementation of cognitive pharmacy services
in Spanish community pharmacy (M. Á 2005).
Non-prescription medication: An international perspective of service provision (F.S. Kelly 2005).
Practice change in community pharmacy: The implementation of cognitive services (A. Roberts
2005).
Evaluation of a model of delivery of patient orientated pharmacy services by pharmacists based in
general medical practices in Australia (P. Whitehead 2005).
Professional collaboration between community pharmacists and general practitioners into
medication regimen review (T. Chen 2001).
Medication review system identifying the at risk elderly (M. Smith 2000).
Training community pharmacists in cognitive behavioural interventions (A. C. de Almeida Neto
2000).
Use of consumer medicine information by community pharmacists ( P.Aslani 1999).
Pharmacoepidemiology of non-prescription drugs (K. Williams 1998).
Use of discrete choice modelling in determining pharmacists’ recommendation of non-prescription
analgesics (S. Roins 1997).
A clinical model for topical antimicrobials (J. Langford 1995).
Schedule 3 medicines and the prescription to non-prescription switch: a survey of community
pharmacists (M. Bowden 1993).
Influences on pharmacists' recommendations of non-prescription products (L. Emmerton 1993).
Non-prescription medication and hypertensive patients (S. Chua 1990).
Services provided by community pharmacy in Queensland (K. Stewart 1989).
5
4.2 M. Pharm
Development of Key Performance Indicators for Australian Community Pharmacy (E. Sissian
2002).
A preventative care service for asthma patients (A. Grzina 2001).
Evaluation of a Topical Antibiotic for Transfer to Non-prescription Status (J. Langford 1991).
Impact of computer dispensing (J. Moshevelis 1985).
Non-prescription Medication Sales in Pharmacy (T. Garde 1984).
Pharmacy Distribution in Queensland (J. Preston 1984).
Effect of Computerisation in Hospital Pharmacy (M. Craig 1984).
Evaluation of Undergraduate Pharmacy Practice Course (M. Ong 1983).
4.3 B. Pharm (Hons)
Development of a research instrument to identify factors affecting practice change in community
pharmacy: experiences with implementation and dissemination of cognitive pharmaceutical
services (A. Roberts 2001).
The provision of drug information via videoconferencing (M. Cocco 1999).
Pharmacist’s practice behaviour with Schedule 3 medicines in community pharmacy (D. Khaicy
1995).
Review of patient medication records to determine possible clinical interventions in community
pharmacy (A. Hannoui 1994).
Factors affecting pharmacists' choice of non-prescription analgesics (S. Roins 1992).
Computerisation of a tracking system for non-prescription medications (G. Mendria 1992).
Use of non-prescription medication by people with diabetes (J. Gaterra 1992).
Consumer decision-making model for cough/cold products (L. Emmerton 1988).
Factors influencing pharmacist selection of non-prescription products (S. Hocart 1989).
4.4 Graduate Diploma of Science
Changing Swiss pharmacists and pharmacist assistant practice in dealing with non-prescription
analgesics (T. Sigrist 1999).
Financial benefits to community pharmacy arising from the delivery of patient drug information
(P. Whitehead 1997).
Provision of a non-prescription professional service: the role of the pharmacy assistant (F.
Kelly 1997).
Implementation of non-prescription professional services into community pharmacies in NSW (R.
Carr 1996).
An economic analysis of pharmacists’ clinical and administrative interventions associated with
the pharmaceutical benefits scheme (S. Caleo 1995).
Financial, work-flow, and drug information impact on professional services from community
pharmacy (S. Ferrington 1994).
Survey and assessment of over-the-counter Chinese herbal medicines (S. Wang 1993).
4.5 Diploma of Hospital Pharmacy
Detection and quantification of errors in discharge medication versus ward medication (1994).
Documentation of pharmacists' clinical intervention - A multicentre study in 4 teaching
hospitals (1993).
Discharge of medication and continuity of treatment (1992).
5. ACADEMIC QUALIFICATIONS, MEMBERSHIPS AND AWARDS
5.1 Academic
B. Pharm. (Hons) 1976, University of Bradford, U.K.
Ph.D. 1980, University of Bradford, U.K.
6
5.2 Memberships
Member, Research Institute for Pharmacy Practice of the University of Granada, 2012 - Present
Member, International Pharmacy Federation, 1987 – Present
Member, Pharmaceutical Society of Australia, 1981 - Present
Member, Royal Pharmaceutical Society of Great Britain, 1977 - Present
Member, Institute of Pharmacy Management International, 1977 - Present
Member, Society of Hospital Pharmacists of Australia, 2004 – 2005
Member, Australian Pharmaceutical Science Association, 1981 – 2005
Member, Australian College of Pharmacy Practice, 1986 - 2000
Member, American Pharmaceutical Association, 1983 - 1990
Member, American Association of College of Pharmacy, 1983 - 1990
5.3 Fellowships and Awards
Commendation of the Gipuzkoa Official Professional Associate of Pharmacists, 2011
Andre Bedat Award from International Federation of Pharmacy, 2010 (Highest award
attainable for significant international contribution to pharmacy practice)
Emeritus Professor, University of Sydney, 2010
Visiting distinguished Professor, University of Granada, 2009 - Present
Fellow, Royal Pharmaceutical Society of Great Britain, 2008
Fellow, Pharmaceutical Society of Australia, 2008
Fellow, International Pharmacy Federation, 2007
Australian Pharmacist of the Year, 2000
Fellow, Australian Institute of Pharmacy Management, 1982
6. POSITIONS HELD
6.1 Employment
Head, Graduate School of Health, University of Technology Sydney, 2011 - Present
Emeritus Professor, University of Sydney, 2011 - Present
Visiting Professor of Pharmacy Practice, University of Granada, July 2009 - Present
Pro-Vice-Chancellor (Strategic Planning), University of Sydney, April 2006 - December 2010
Acting Pro-Vice-Chancellor, College of Health Sciences, University of Sydney, October 2005 -
April 2006.
Assistant Pro-Vice-Chancellor, (College of Health Sciences) and Director Economic Model
Development, University of Sydney, July 2005 - October 2005.
Dean, Faculty of Pharmacy, University of Sydney, 2000 - 2005
Head of Department, Pharmacy, University of Sydney, 1996 - 1999
Foundation Professor of Pharmacy Practice, Faculty of Pharmacy, University of Sydney, 1991 -
2010
Senior Lecturer in Pharmacy, University of Queensland, 1986 - 1991
7. OTHER EXPERIENCE
7.1 Sabbatical University of Granada Spain September 2009 – November 2010 Fifteen months as a visiting professor of Granada undertaking two projects
(a) The Impact of Medication Review with follow up (SFT) on geriatric patients with
multiple medications
(b) Adherence in asthmatic patients
7
7.2 Special Studies Programme July 1988 – January 1989
Six months were spent at Reckitt and Colman Pharmaceutical Division, Hull, England,
working in the Marketing and Clinical departments, undertaking research into:
(a) New product development for non-prescription medications,
(b) Education and training on non-prescriptions medications, and
(c) Review of CRM and CSM regulatory requirements for OTC medication.
7.4 Special Studies Programme January 1985 – June 1985
Six months were spent at the University of Mississippi participating in three research
projects:
(a) Ibuprofen 200mg - utilisation and determinants of use,
(b) O.T.C. medication sales - a comparative study, and
(c) Review of F.D.A. work on OTC products.
8. SERVICE
8.1 University of Technology Sydney
Member, Academic Board, 2011 – Present
Chair, Graduate School of Health Board, 2010
Member, Pharmacy Industry Advisory Board, 2011
8.2 University of Sydney Member, Financial Strategy Board, 2006 - 2009
Member, Provost Academic Strategy Group, 2006 - 2009
Member, Chief Operations Officer Advisory Board, 2006 - 2009
Member, University Financial Services Board of Management, 2005 - 2009
Member, University Budget, Planning and Capital Management Board, 2005 - 2009
Member, University Project Board - Management Reporting Project, 2005 - 2009
Member, Vice Chancellor Advisory Committee, 2000 - 2009
Member, Senior Executive Group, 2005 - 2006
Chair, College of Health Sciences Financial Services Board of Management, 2005 - 2006
Chair, College of Health Sciences Teaching and Learning Committee, 2005 - 2006
Chair, College of Health Sciences Basic Sciences Review Committee, 2005 - 2006
Chair, College of Health Sciences EdHealth Conference Planning Committee, 2005 - 2006
Member, Academic Board, 1992 - 2005
Member, College Management Advisory Committee, 1999 - 2005
Member, Centre for Continuing Education Advisory Committee, 2005
Chair, Faculty of Pharmacy Board, 2000 - 2005
Member, Academic Staffing Committee, 2002 - 2005
Member, University Travel Board, 2003 - 2005
Member, University Fees Committee, 2004 - 2005
Member, International Strategic Committee, 2003 - 2004
Chair, Committee of Deans, 2002 - 2004
Member, Committee of Deans, 2000 - 2004
Member, Centre for Regional Education Orange (CREO), 2001 - 2004
Member, Quality Assurance Co-ordination Group (AUQA), 2001 - 2004
Member, Management Information Systems, 2001 - 2004
Co-chair, Bachelor of Pharmacy (Rural) Professional Advisory Committee, 2001 - 2002
Chair, Bachelor of Pharmacy (Rural) Curriculum Committee, Faculty of Pharmacy, 2001 - 2002
Member, Policy Advisory Committee, Department of Pharmacy, 1993 - 2000
Member, Departmental Board, Department of Pharmacy, 1992 - 1999
Member, Faculty of Science Board, 1993 - 1999
8
Chair, Faculty of Pharmacy Implementation Committee, 1997 - 1999
Member of the Standing Committee of the Academic Board, 1997 - 1998
Chair, Departmental Review Committee, 1996 - 1997
Member, Technical Services Committee, Department of Pharmacy, 1993 - 1996
Chair, Fourth Year Professional Advisory Group, Department of Pharmacy, 1994 - 1996
Chair, Fourth Year Working Party, Department of Pharmacy, 1994 - 1996
Member, Undergraduate Courses Committee, Department of Pharmacy, 1994 - 1996
Chair, Staff Liaison Committee, Department of Pharmacy, 1994 - 1995
Member, Faculty of Science Review of Degree Committee, 1994
8.3 University of Queensland Member, Faculty of Medicine, 1990 - 1991
Chair, Continuing Education Committee, Department of Pharmacy, 1989 - 1991
Chair, Subcommittee on Scientific Staff, Department of Pharmacy, 1989 - 1991
Chair, Planning and Finance Committee, Department of Pharmacy, 1988 - 1991
Chair, Education Committee, Department of Pharmacy, 1987 - 1989
Member, Hospital/University Joint Pharmacy Appointment Committee, 1987 - 1988
8.4 Professional Organisations Branch Committee Member, Pharmaceutical Society of Australia, 2008 - Present
Chair, Innovators Forum International Pharmaceutical Federation, 2006 - Present
Co-Chair, Pharmacy Practice Research FIP, 2012 - 2014
President, Pharmaceutical Society of Australia New South Wales Branch, 2011 - 2012
National Councillor, National Council Pharmaceutical Society of Australia, 2005 - 2008
President, Pharmaceutical Society of Australia New South Wales Branch, 2004 - 2008
Board member, Pharmacy Practice Foundation Council, 1991 - 2008
Executive member, Pharmacy Practice Foundation, 1991 - 2008
Chair, Continuing Education Committee Community Pharmacy section, International
Pharmaceutical Federation, 2001- 2006
Chair, Education Committee, International Pharmaceutical Federation, Sydney, 2003 - 2006
NSW Representative, Pharmaceutical Society of Australia Transition Authority, 2004 - 2006
Executive member of the Pharmacy Alumni Association, 1996 - 2005
Chair, Education Planning Committee, International Pharmaceutical Federation, 2001 - 2004
Vice President, Pharmaceutical Society of Australia (New South Wales), 2001 - 2004
National Treasurer, Pharmaceutical Society of Australia, 2002 - 2003
Member, Pharmaceutical Society of Australia National Executive, 2002 - 2003
Member, Pharmaceutical Society of Australia Practice Support Taskforce, 2002 - 2003
Member, Pharmaceutical Society of Australia Schedule 3 Committee, 1993 - 2003
Member, Australian Host Committee, International Pharmaceutical Federation, Sydney 2003
Member, National Pharmacy Workforce Reference Group, 1998 - 2001
Member, Summit Pharmacy Group, 1996 - 2000
Board member, Australian Pharmacy Research Centre, 1991 - 2000
Member, National Advisory Group Australian Association of Consultant Pharmacists, 1998 -1999
Member, Administrative Committee, Pharmacy Board of NSW, 1996 - 1998
Chair, Marion Merrell Dow Non-Prescription Advisory Committee, 1994 - 1998
Member, Pharmacy Board of New South Wales, 1993 - 1998
Member, Education Committee, Pharmacy Board of New South Wales, 1993 - 1998
Member, Australian Pharmacy Consultant Group, 1994 - 1998
Member, Pharmaceutical Society of Australia National Continuing Education Committee, 1994 -
1998
Member, National Advisory Group Pharmaceutical Care Project, Pharmaceutical Society of
Australia, 1994 - 1997
9
Member, Technical Advisory Group, Pharmacy/Australian Pharmacy Research Centre, 1993 -
1995
Academic Advisory Board member, Australian College of Pharmacy Practice, 1987 - 1997
Member of the Australian Brain Foundation Committee, 1986 - 1987
Panel member, Australian College of Pharmacy Practice Project, Pharmaceutical Society of
Australia, 1984
Member, Academic Advisory Board of the Australian College of Pharmacy Practice, 1984 - 1997
Member, Continuing Education Committee, Pharmaceutical Society of Australia (Qld), 1984 -
1988
Member, Pre-registration Committee, Pharmaceutical Society of Australia (Qld), 1984 - 1988
Member, Pre-registration Committee of the Pharmacy Board of Queensland, 1981 - 1984
Member, Pharmacy Practice Committee, Pharmaceutical Society of Australia (Qld), 1981 - 1985
President, British Pharmaceutical Students Association, 1976 - 1977
9. PUBLICATIONS
9.1 Thesis 1. Benrimoj, S.I. Pharmacy in Health Centre Areas, Vols. I & II. University of Bradford, Ph.D.
(1980).
9.2 Books, Manuals and Editor of Conference Proceedings 1. Roberts, A., Benrimoj, S. I., Dunphy, D. C., & Palmer, I. C. (2007). Community Pharmacy:
Strategic Change Management (1 ed.). Australia: McGraw Hill.
2. Benrimoj, S.I. (ed) (2002). Professional Development Program: How to disseminate a
professional service that is being paid. Proceedings of the Community Pharmacy Section, 62nd
World Congress of Pharmacy and Pharmaceutical Sciences, International Pharmaceutical
Federation
3. Benrimoj, S.I. (ed) (2002) How to Achieve, Plan and Deliver a Professional Service that is Being
Paid Part I – Remuneration. Proceedings of the Community Pharmacy Section, 62nd
World
Congress of Pharmacy and Pharmaceutical Sciences, International Pharmaceutical Federation.
4. Chen, T. F., Whitehead, M., Williams, K., Moles, R., Aslani, P., & Benrimoj, S. I. (2002).
Case studies in Practice Medication review: A process guide for pharmacists.. Sydney: PSA
Publishing.
5. Benrimoj, S.I. (ed) (2001) Improve your professional practice with customers seeking self-care
and OTC medications. Proceedings of the Community Pharmacy Section, World Congress of
Pharmacy and Pharmaceutical Sciences, International Pharmaceutical Federation.
6. Benrimoj, S. I., & Cusack, B. (1998). Drug information for community pharmacists:
geriatrics. Brisbane: University of Queensland, Department of Pharmacy.
7. Cusack, B., & Benrimoj, S. I. (1998). Pest Management - Future Challenges 6th Australasian
Applied Entomological Research Conference. Brisbane: University of Queensland.
8. Benrimoj, S. I., & Langford, J. (1997). Antibiotics drug information for community
pharmacists. Brisbane: University of Queensland.
9. Harrison, F., & Benrimoj, S. I. (1994). Clinical Case Studies for Community Pharmacists
Prescription Drugs. Brisbane: University of Queensland.
10. Benrimoj, S. I., & Harrison, F. (1994). Drug Information for Community Pharmacists
Analgesics. Brisbane: University of Queensland.
11. Benrimoj, S. I., & Harrison, F. (1994). Drug information for community pharmacists.
Dermatology (1 ed.). Brisbane: University of Queensland.
12. Robinson, M. T., & Benrimoj, S. I. (1993). Drug Information for Community Pharmacists
Antihypertensive Drugs. Brisbane: University of Queensland.
13. Benrimoj, S. I., Robinson, M. T., & Stewart, K. (1992). Clinical Case Studies for Community
Pharmacists A Case for Counselling. Brisbane: University of Queensland.
10
14. Robinson, M., Benrimoj, S. I., Kot, T., Dight, D., Parker, J., & Ferrington, S. (1992). Drug
Information for Community Pharmacists Drugs for Mood Disorders. Brisbane: University of
Queensland.
15. McKauge, L., & Benrimoj, S. I. (1992). Drug Information for Community Pharmacists Over-
the-counter drugs, coughs and colds. Brisbane: University of Queensland.
16. Robinson, M., Benrimoj, S. I., Kott, T., Dight, D., & Parker, J. (1992). Drug information for
community pharmacists. Drugs for mood disorders. Brisbane: University of Queensland.
17. Benrimoj, S. I., & Wright, A. H. (1985). Pharmacist's Guide to Proprietary Product
Schedules. Queensland: Pharmacy Guild of Australia.
18. Benrimoj, S. I., Roush, P. J., & McGuire, T. (1982). Counter Prescribing - With particular
emphasis on the O.T.C. areas of coughs and colds, and pain.. Queensland: Pharmaceutical
Society of Australia.
9.3 Major Research Reports
1. Benrimoj, S. I. Identify a best practice model for the integration of community pharmacists in
the primary health care setting. (in conjunction with PWC , Sydney Australia)
2. Benrimoj, S.I. 2010. Estudio piloto: medida del impacto clínico, económico y humanístico
seguimiento farmacoterapeutico en mayores poli medicados, Ministerio de salud y política
social. ISBN 978-84-8473-931-9.
3. Benrimoj, S.I., Feletto E., Wilson, L. 2009. Building organisational flexibility to promote the
implementation of primary care services in community pharmacy Australian Government
Department of Health and Ageing.
4. Benrimoj, S.I., Wilson, F. 2005. Standards for the Provision of Pharmacy Medicines and
Pharmacist Only Medicines in Community Pharmacy Revised.
5. Benrimoj, S.I., Frommer, M., Rychetnik, L., Holt, P., Heinke, M., Madronio, C., George, M.,
Reitano, R. Community Pharmacy Research Support Centre Report Series, Report 1: The
Value of Professional Pharmacist Services in the Community Setting: A systematic Review of
the Literature (Oct 2002-March 2005) 2005, Australian Government Department of Health and
Ageing.
6. Moles, R., Benrimoj, S.I., Brien, J. Professional Pharmacy Services to Private Hospital Patients
2005, Australian Government Department of Health and Ageing.
7. Dunphy, D. and Benrimoj, S.I. 2005. The Shape of Our Future: Change Management and
Community Pharmacy Project. Australian Government Department of Health and Ageing.
8. Benrimoj, S.I., et. al. A Cost-Benefit Analysis of Pharmacist Only (S3) and Pharmacy
Medicines (S2) and Risk-Based Evaluation of the Standards. 2005. Australian Government
Department of Health and Ageing.
9. Benrimoj, S.I. and Roberts, A., et. al. Quantification of Facilitators to Accelerate Uptake of
Cognitive Pharmaceutical Services (CPS) in Community Pharmacy, 2004, Australian
Government Department of Health and Ageing.
10. Benrimoj, S.I. and Roberts, A., et. al. An Investigation into Business and Professional
Facilitators for Change for the Pharmacy Profession in Light of the Third Guild/Government
Agreement. 2003. Commonwealth Department of Health and Ageing.
11. Benrimoj, S.I. and Gilbert, A. Implementation mechanisms to raise standards of practice re
supply of pharmacy and pharmacy only medicines in community pharmacy. 2002.
Commonwealth Department of Health and Aged Care.
12. Benrimoj, S.I., Emerson, L., Kopecny, E., Peacocke, G. Whitehead, P. The Best Pharmacy
Practice for Alternate Pharmacy Arrangement Project Report. 1999. Commonwealth
Department of Health and Aged Care.
13. Aslani, P., Benrimoj, S.I., Emerson, L. Consumers and Community Pharmacy. 1999. The
Pharmacy Guild of Australia. ISSN 1440-2270.
14. Crampton, M., Benrimoj, S.I., Gilbert, A., Quintell, N. Standards of Practice for the Provision
of Pharmacist Only and Pharmacy Medicines in Community Pharmacy. 1998. Commonwealth
Department of Health and Aged Care.
11
15. Emerson, L., Whitehead, P., Benrimoj, S.I. The Value of Professional Pharmacist Services.
1998. The Pharmacy Guild of Australia. ISSN 1440-2270.
16. Benrimoj, S.I., Langford, J.H., Berry, G., Collins, D., Lauchlan, R., Stewart, K. A Randomised
Trial on the Effect of Education and a Professional Allowance on Clinical Intervention Rates in
Pharmacy: clinical and cost evaluation. 1997. Commonwealth Department of Health and Aged
Care.
17. Chen, T., Crampton, M., Krass, I., Benrimoj, S.I. Medication Regimen Reviews: a collaborative
project between community pharmacists and general medical practitioners. Final Report -
Development, Implementation and Evaluation of Intervention. 1997. Commonwealth Department
of Health and Aged Care.
18. Caleo, S., Benrimoj, S.I., Ausburn, L., Baume, P., Collins, D., Hall, J., Lauchlan, R., Stewart, K.
An Economic Analysis of Pharmacists' Intervention associated with the Pharmaceutical Benefits
Scheme - Pilot Study. Feb 1995. Australian Pharmacy Research Centre.
19. Caleo, S., Benrimoj, S.I., Ausburn, L., Baume, P., Collins, D., Hall, J., Lauchlan, R., Stewart, K.
An Economic Analysis of Pharmacists' Clinical and Administrative Interventions associated with
the Pharmaceutical Benefits Scheme - Part II - Pilot Study. Oct 1994. Australian Pharmacy
Research Centre.
20. Ferrington, S. and Benrimoj, S.I. Impact of Professional Services in API Health Care Community
Pharmacies. Sept 1994. Australian Pharmaceutical Industry.
21. Benrimoj, S.I. Drug Distribution Systems; Automation - Part 2. 1993. Information Systems, NSW
Health Department.
22. Benrimoj, S.I. Drug Distribution Systems; A Review - Part 1. 1993. Information Systems, NSW
Health Department.
23. Benrimoj, S.I., and Dight, D. Survey of professional services and attitudes of API Healthcare
pharmacists. 1993. Australian Pharmaceutical Industry.
24. Benrimoj, S.I., Stewart, K., Robinson, M. Non-Prescription Medication Consumer Survey, 1987.
The Medicine Group, Sydney, 1988.
9.4 Refereed Journal Articles
1. Malet-Larrea A, Arbillaga L, Gastelurrutia MÁ, Larrañaga B, Garay Á, Benrimoj SI,
Oñatibia-Astibia A, Goyenechea E. Defining and characterising age-friendly community
pharmacies: a qualitative study. Int J Pharm Pract 2018 Apr 24. doi: 10.1111/ijpp.12451.
2. Benson H, Lucas C, Kmet W, Benrimoj SI, Williams K. Pharmacists in general practice:
a focus on drug-related problems. Int J Clin Pharm 2018 Mar 14. doi: 10.1007/s11096-
018-0617-9.
3. Franco-Trigo L, Tudball J, Fam D, Benrimoj SI, Sabater-Hernández D. A stakeholder
visioning exercise to enhance chronic care and the integration of community pharmacy
services. Res Social Adm Pharm 2018 Feb 21. pii: S1551-7411 (17) 30736-2. doi:
10.1016/j.sapharm.2018.02.007.
4. Sabater-Hernández D, Tudball J, Ferguson C, Franco-Trigo L, Hossain LN, Benrimoj SI.
A stakeholder co-design approach for developing a community pharmacy service to
enhance screening and management of atrial fibrillation. BMC Health Serv Res 2018 Feb
27; 18 (1): 145. doi: 10.1186/s12913-018-2947-7.
5. Aly M, García-Cárdenas V, Williams K, Benrimoj SI. A review of international
pharmacy-based minor ailment services and proposed service design model. Res Social
Adm Pharm 2018 Jan 5. pii: S1551-7411 (17) 30896-3. doi:
10.1016/j.sapharm.2017.12.004.
6. Crespo-Gonzalez C, Fernandez-Llimos F, Rotta I, Correr CJ, Benrimoj SI, Garcia-
Cardenas V. Characterization of pharmacists' interventions in asthma management: A
12
systematic review. J Am Pharm Assoc (2003). 2018 Mar - Apr; 58 (2): 210-219. doi:
10.1016/j.japh.2017.12.009.
7. Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic
impact of medication non-adherence by disease groups: a systematic review. BMJ Open
2018 Jan 21; 8 (1): e016982. doi: 10.1136/bmjopen-2017-016982.
8. Aly M, García-Cárdenas V, Williams K, Benrimoj SI. WITHDRAWN: A Review Of
International Pharmacy- Based Minor Ailment Services And Proposed Service Design
Model. Res Social Adm Pharm 2017 Dec 16. pii: S1551-7411 (17) 30469-2. doi:
10.1016/j.sapharm.2017.12.006.
9. Hossain LN, Tudball J, Franco-Trigo L, Durks D, Benrimoj SI, Sabater-Hernández D. A
multilevel stakeholder approach for identifying the determinants of implementation of
government-funded community pharmacy services at the primary care level. Res Social
Adm Pharm 2017 Oct 5. pii: S1551-7411 (17) 30549-1. doi:
10.1016/j.sapharm.2017.10.001.
10. Hossain LN, Fernandez-Llimos F, Luckett T, Moullin JC, Durks D, Franco-Trigo L,
Benrimoj SI, Sabater-Hernández D. Qualitative meta-synthesis of barriers and facilitators
that influence the implementation of community pharmacy services: perspectives of
patients, nurses and general medical practitioners. BMJ Open 2017 Sep 5; 7 (9): e015471.
doi: 10.1136/bmjopen-2016-015471. Erratum in: BMJ Open. 2018 Mar 8; 8 (3):
e015471corr1.
11. Crespo-Gonzalez C, Garcia-Cardenas V, Benrimoj SI. The next phase in professional
services research: From implementation to sustainability. Res Social Adm Pharm 2017
Sep - Oct; 13 (5): 896-901. doi: 10.1016/j.sapharm.2017.05.020.
12. Fuller JM, Saini B, Bosnic-Anticevich S, Garcia Cardenas V, Benrimoj SI, Armour C.
Testing evidence routine practice: Using an implementation framework to embed a
clinically proven asthma service in Australian community pharmacy. Res Social Adm
Pharm 2017 Sep - Oct; 13 (5): 989-996. doi: 10.1016/j.sapharm.2017.05.019. 13. Garcia-Cardenas, V., Castrillon Ocampo, C., Martinez-Martinez, F., Benrimoj, S. I., Amariles, P.,
& Gastelurrutia, M. A. (2015). Implementation of medication review with follow-up in a Spanish
community pharmacy and its achieved outcomes. International Journal of Clinical Pharmacy.
doi: 10.1007/s11096-015-0145-9
14. Mossialos, E., Courtin, E., Naci, H., Benrimoj, S., Bouvy, M., Farris, K., Sketris, I. (2015). From
“retailers” to health care providers: Transforming the role of community pharmacists in chronic
disease management. Health Policy, 119(5), 628-639.
15. Jódar-Sánchez, F., Malet-Larrea, A., Martín, J. J., García-Mochón, L., López Del Amo, M. P.,
Martínez-Martínez, F., Benrimoj, S. I. (2015). Cost-Utility Analysis of a Medication Review with
Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The
conSIGUE Program. PharmacoEconomics, 33(6), 599-610.
16. Sabater-Hernández, D., Sendra-Lillo, J., Jiménez-Monleón, J. J., Benrimoj, S. I., Durks, D.,
Martínez-Martínez, F., De La Sierra, A. (2015). Identifying masked uncontrolled hypertension in
the community pharmacy setting. Blood Pressure Monitoring, 20(3), 138-143.
17. Moullin, J. C., Sabater-Hernández, D., Fernandez-Llimos, F., & Benrimoj, S. I. (2015). A
systematic review of implementation frameworks of innovations in healthcare and resulting
generic implementation framework.. Health research policy and systems / BioMed Central, 13(1),
16. doi:10.1186/s12961-015-0005-z
18. Salgado, T. M., Arguello, B., Martinez-Martinez, F., Benrimoj, S. I., & Fernandez-Llimos, F.
(2014). Lack of harmonisation in the classification of renal impairment in European Summaries of
Product Characteristics. Internal Medicine Journal, 45(6), 686-687.
19. Salgado, T. M., Moles, R., Benrimoj, S. I., & Fernandez-Llimos, F. (2014). Renal nurses' views of
the potential role of pharmacists in outpatient dialysis centres: A qualitative study. International
Journal of Pharmacy Practice, 22(4), 300-303.
13
20. Benrimoj, S. I., Lim, L., & Capezio, L. (2014). A Diabetes MedsCheck Implementation Pilot
Program. Australian Pharmacist, 4(47), 68-74.
21. Noain, M. A., Gastelurrutia, M. A., Martínez-Martínez, F., & Benrimoj, S. I. (2014). Costs'
identification of the sustainable provision of the Medication Management Service.
Pharmaceutical Care Espana, 16(5), 180-192.
22. Moullin, J. C., Sabater Hernandez, D., & Benrimoj, S. I. (2014). Implementing professional
pharmacy services. Australian Pharmacist, 33(4), 13-14.
23. Pérez-Escamilla, B., García-Cárdenas, V., Gastelurrutia, M. A., Varas, R., Sáez-Benito, L.,
Martínez-Martínez, F., Benrimoj, S. I. (2014). Perception of Practice Change Facilitators on the
professional future of this new job in community pharmacy. Pharmaceutical Care Espana, 16(3),
81-88.
24. Salgado, T. M., Arguello, B., Martinez-Martinez, F., Benrimoj, S. I., & Fernandez-Llimos, F.
(2013). Is information for dose adjustment in renal impairment contained in Summaries of
Product Characteristics suitable for integration in clinical decision support systems?. International
Journal of Clinical Pharmacy, 35(6), 1271.
25. Salgado, T. M., Ramos, S. B., Clesia, S., Canas, R., Cunha, I., Benrimoj, S. I., Fernandez-Llimos,
F. (2013). Utility of the Newest Vital Sign to assess health literacy in community-dwelling older
adults. International Journal of Clinical Pharmacy, 35(5), 984.
26. Moullin, J. M., Sabater-Hernandez, D., & Benrimoj, S. I. (2013). Defining professional pharmacy
services-the role of community pharmacy. International Journal of Clinical Pharmacy, 35(3),
493-494.
27. Sabater-Hernandez, D., de la Sierra, A., Sendra-Lillo, J., Benrimoj, S. I., Martinez-Martinez, F.,
& Faus, M. J. (2013). Predictors of masked hypertension in the community pharmacy setting.
International Journal of Clinical Pharmacy, 35(3), 494.
28. Salgado, T. M., Correr, C. J., Moles, R., Benrimoj, S. I., & Fernandez-Llimos, F. (2013).
Assessing the Implementability of Clinical Pharmacist Interventions in Patients With Chronic
Kidney Disease: An Analysis of Systematic Reviews. Annals of Pharmacotherapy, 47(11), 1498-
1506.
29. Salgado, T. M., Arguello, B., Martinez-Martinez, F., Benrimoj, S. I., & Fernandez-Llimos, F.
(2013). Clinical relevance of information in the Summaries of Product Characteristics for dose
adjustment in renal impairment. European Journal of Clinical Pharmacology, 69(11), 1973-1979.
30. Salgado, T., Marques, A., Geraldes, L., Benrimoj, S., Horne, R., & Fernandez-Llimos, F. (2013).
Cross-cultural adaptation of the Beliefs about Medicines Questionnaire into Portuguese. Sao
Paulo Medical Journal, 131(2), 88-94.
31. Moullin, J. C., Sabater Hernandez, D., Fernandez-llimos, F., & Benrimoj, S. I. (2013). Defining
professional pharmacy services in community pharmacy. Research In Social & Administrative
Pharmacy, 9(6), 989-995.
32. García-Cárdenas, V., Sabater-Hernández, D., Kenny, P., Martínez-Martínez, F., Faus, M. J., &
Benrimoj, S. I. (2013). Effect of a pharmacist intervention on asthma control. A cluster
randomised trial. Respiratory Medicine, 107(9), 1346-1355.
33. Sáez-Benito, L., Fernandez-Llimos, F., Feletto, E., Gastelurrutia, M. A., Martinez-Martinez, F., &
Benrimoj, S. I. (2013). Evidence of the clinical effectiveness of cognitive pharmaceutical services
for aged patients. Age and Ageing, 42(4), 442-449.
34. Salgado, T. M., Moles, R., Benrimoj, S. I., & Fernandez-Llimos, F. (2013). Exploring the role of
pharmacists in outpatient dialysis centers: A qualitative study of nephrologist views. Nephrology
Dialysis Transplantation, 28(2), 397-404.
35. Martínez-Martínez, F., García-Cárdenas, V., Sáez-Benito, L., Varas, R., Ángel Gastelurrutia, M.,
Sabater-Hernández, D., Benrimoj, S. I. (2013). Get Impact Program. Evaluation clinical impact,
economic and humanistic Pharmacotherapy follow adults greater polypharmacy. Vitae,
20(SUPPL. 1).
36. Moullin, J. C., Sabater-Hernández, D., & Benrimoj, S. I. (2013). Letter of response to
correspondence regarding article "Defining professional pharmacy services in community
pharmacy". Research in Social and Administrative Pharmacy, 9(4), 492.
14
37. Salgado, T. M., Ramos, S. B., Sobreira, C., Canas, R., Cunha, I., Benrimoj, S. I., Fernandez-
Llimos, F. (2013). Newest vital sign as a proxy for medication adherence in older adults. Journal
of the American Pharmacists Association, 53(6), 611-617.
38. Gil Garcia, M., Benrimoj, S. I., Martinez-Martinez, F., Cardero Rivas, M., & Gastelurrutia
Garralda, M. (2013). Opinion of a group of experts on facilitators for introducing
pharmacotherapy follow up in Spanish communities. Community Pharmacists, 5(3), 96-102.
39. Gil, M. I., Benrimoj, S. I., Martínez-Martínez, F., Cardero, M., & Gastelurrutia, M. Á. (2013).
Priorization of facilitators for the implementation of medication review with follow-up service in
Spanish community pharmacies through exploratory factor analysis. Atencion Primaria, 45(7),
368-375.
40. García-Cárdenas, V., Sabater-Hernández, D., García-Corpas, J. P., Faus, M. J., Martínez-
Martínez, F., & Benrimoj, S. I. (2012). Errors in turbuhaler technique in a Spanish population of
asthmatic patients. Respiratory Care, 57(5), 817-818.
41. Salgado, T. M., Moles, R., Benrimoj, S. I., & Fernandez-Llimos, F. (2012). Exploring the role of
renal pharmacists in outpatient dialysis centres: A qualitative study. International Journal of
Clinical Pharmacy, 34(4), 569-578.
42. García-Cárdenas, V., Gastelurrutia, M. Á., Benrimoj, S. I., Martínez-Martínez, F., & Faus, M. J.
(2012). Factors affecting community pharmacists' participation in a Pharmaceutical care service
for asthmatic patients. Pharmaceutical Care Espana, 14(1), 19-27.
43. García-Cárdenas, V., Sabater-Hernández, D., Faus, M. J., Martínez-Martínez, F., & Benrimoj, S.
I. (2012). Is the inhaler technique associated with asthma control?. Journal of Asthma, 49(2), 170-
171.
44. Salgado, T., Benrimoj, S. I., Moles, R., & Fernandez-Llimos, F. (2012). Pharmaceutical Services
in patients with insufficient renal function. Acta Farmaceutica Portuguesa, 1(2), 59-69.
45. Salgado, T. M., Moles, R., Benrimoj, S. I., & Fernandez-Llimos, F. (2012). Pharmacists'
interventions in the management of patients with chronic kidney disease: A systematic review.
Nephrology Dialysis Transplantation, 27(1), 276-292.
46. Salgado, T. M., Moles, R., Benrimoj, S. I., & Fernandez-Llimos, F. (2011). Designing a model to
minimize inequities in hemodialysis facilities distribution. Geospatial Health, 6(1), 5-12.
47. Feletto, E., Wilson, L. K., Roberts, A. S., & Benrimoj, S. I. (2011). Measuring organizational
flexibility in community pharmacy: Building the capacity to implement cognitive pharmaceutical
services. Research in Social and Administrative Pharmacy, 7(1), 27-38.
48. Gastelurrutia, P., Benrimoj, S. I., Espejo, J., Tuneu, L., Mangues, M. A., & Bayes-Genis, A.
(2011). Negative clinical outcomes associated with drug-related problems in heart failure (HF)
outpatients: Impact of a pharmacist in a multidisciplinary HF clinic. Journal of Cardiac Failure,
17(3), 217-223.
49. Williams, K. A., Emmerton, L. M., Taylor, R., Werner, J., & Benrimoj, S. I. (2011). Non-
prescription medicines and Australian community pharmacy interventions: Rates and clinical
significance. International Journal of Pharmacy Practice, 19(3), 156-165.
50. Sabater, M., Feletto, E., Martínez-Martínez, F., Gil, M. I., Gastelurrutia, M. Á., & Benrimoj, S. I.
(2011). Perception of the polymedicated elderly patient about the community pharmacist's role.
Pharmaceutical Care Espana, 13(6), 271-279.
51. Gastelurrutia, M. Á., Feletto, E., Noain, M. A., Martínez-Martínez, F., Varas, R., & Benrimoj, S.
I. (2011). Pharmacist experience of delivering medication reviews with follow up within the
project conSIGUE. Pharmaceutical Care Espana, 13(6), 280-288.
52. Feletto, E., Wilson, L. K., Roberts, A. S., & Benrimoj, S. I. (2010). Building capacity to
implement cognitive pharmaceutical services: Quantifying the needs of community pharmacies.
Research in Social and Administrative Pharmacy, 6(3), 163-173.
53. Lenzen, M., Benrimoj, S., & Kotic, B. (2010). Input-Output analysis for business planning: A
case study of the University of Sydney. Economic Systems Research, 22(2), 155-179.
54. Benrimoj, S. I., Feletto, E., Gastelurrutia, M. A., Martinez Martinez, F., & Faus, M. J. (2010). A
holistic and integrated approach to implementing cognitive pharmaceutical services. Ars
Pharmaceutica, 51(2), 69-88.
15
55. Paulino, E., Guerreiro, M., Cantrill, J., Martins, A., Alves Da Costa, F., & Benrimoj, S. I. (2010).
Community Pharmacists' and physicians' inter-professional work: Insights from qualitative studies
with multiple stakeholders. Revista Portuguesa de Clínica Geral, 26, 590-606.
56. Feletto, E., Wilson, L. K., Roberts, A. S., & Benrimoj, S. I. (2010). Flexibility in community
pharmacy: A qualitative study of business models and cognitive services. Pharmacy World and
Science, 32(2), 130-138.
57. Feletto, E., Wilson, L. K., Roberts, A. S., & Benrimoj, S. I. (2009). Strategies for sustaining
pharmaceutical care services (PCS) in Australian community pharmacies. Pharmacy World and
Science, 31(4), 497.
58. Feletto, E., Wilson, L. K., Roberts, A. S., & Benrimoj, S. I. (2009). The development of a tool to
measure community pharmacy's capacity for implementing pharmaceutical care services.
Pharmacy World and Science, 31(4), 500-501.
59. Kelly, F. S., Williams, K. A., & Benrimoj, S. I. (2009). Does advice from pharmacy staff vary
according to the nonprescription medicine requested?. Annals of Pharmacotherapy, 43(11), 1877-
1886.
60. Gastelurrutia, M. A., Benrimoj, S. I. C., Castrillon, C. C., De Amezua, M. J. C., Fernandez-
Llimos, F., & Faus, M. J. (2009). Facilitators for practice change in Spanish community
pharmacy. Pharmacy World and Science, 31(1), 32-39.
61. Benrimoj, S. I., Gilbert, A. L., De Almeida Neto, A. C., & Kelly, F. (2009). National
implementation of standards of practice for non-prescription medicines in Australia. Pharmacy
World and Science, 31(2), 230-237.
62. Werner, J. B., & Benrimoj, S. I. (2008). Audio taping simulated patient encounters in community
pharmacy to enhance the reliability of assessments.. Am J Pharm Educ, 72(6), 136.
63. Benrimoj, S. I., Werner, J. B., Raffaele, C., & Roberts, A. S. (2008). A system for monitoring
quality standards in the provision of non-prescription medicines from Australian community
pharmacies. Pharmacy World and Science, 30(2), 147-153.
64. Krass, I., Benrimoj, S. I., & Emerson, L. (2008). Evaluation of an interdisciplinary continuous
quality improvement (CQI) approach to improving cardiovascular risk in rural Australia.
International Journal of Pharmacy Practice, 16(SUPPL. 1).
65. Roberts, A. S., Benrimoj, S. I., Chen, T. F., Williams, K. A., & Aslani, P. (2008). Practice change
in community pharmacy: Quantification of facilitators. Annals of Pharmacotherapy, 42(6), 861-
868.
66. Dolcet, H. O., Benrimoj, S. I., & Fernandez-Llimos, F. (2007). A theoretical framework for the
implementation of patient-oriented pharmacy services using a quality management system.
Pharmacy World and Science, 29(6), 709.
67. Feletto, E., Oller, D. H., Fernandez-Llimos, F., Roberts, A., & Benrimoj, S. I. (2007). An
international approach to linking quality systems and business capabilities to enhance viability
and the implementation of patient orientated services in community pharmacy. Pharmacy World
and Science, 29(6), 711-712.
68. Benrimoj, S. I., Werner, J. B., Raffaele, C., Roberts, A. S., & Costa, F. A. (2007). Monitoring
quality standards in the provision of non-prescription medicines from Australian Community
Pharmacies: Results of a national programme (Quality and Safety in Health Care (2007) 16, (354-
358)). Quality and Safety in Health Care, 16(6), 461. doi:10.1136/qshc.2006.019463corr1
69. Feletto, E., Roberts, A., & Benrimoj, S. I. (2007). Optimising business viability in Australian
community pharmacies by integrating cognitive pharmacy services. Pharmacy World and
Science, 29(6), 713.
70. Moles, R. J., Brien, J. -A. E., & Benrimoj, S. I. (2007). New South Wales private hospitals and
their pharmacy services. Journal of Pharmacy Practice and Research, 37(2), 119-123.
71. Feletto, E., Dunphy, D., Palmer, I., & Benrimoj, S. I. (2007). An industry approach to practice
change in community pharmacy. Pharmacy World and Science, 29(6), 712.
72. Gastelurrutia, M. Á., Fernández-Llimos, F., Benrimoj, S. I., Castrillon, C. C., & Faus, M. J.
(2007). Barriers for the implementation of cognitive services in Spanish community pharmacies.
Atencion Primaria, 39(9), 465-470.
16
73. Aslani, P., Benrimoj, S. I., & Krass, I. (2007). Development and evaluation of a training program
to foster the use of written drug information in community pharmacies. Part 2: Evaluation.
Pharmacy Education, 7(2), 141-149.
74. Benrimoj, S. I., Werner, J. B., Raffaele, C., Roberts, A. S., & Costa, F. A. (2007). Monitoring
quality standards in the provision of non-prescription medicines from Australian Community
Pharmacies: Results of a national programme. Quality and Safety in Health Care, 16(5), 354-358.
75. Benrimoj, S. I., Gilbert, A., Quintrell, N., & De Almeida Neto, A. C. (2007). Non-prescription
medicines: A process for standards development and testing in community pharmacy. Pharmacy
World and Science, 29(4), 386-394.
76. Feletto, E., Dunphy, D., Palmer, I., Benrimoj, S. I., & Roberts, A. (2007). Practice change in
community pharmacy - tools for service implementation. Pharmacy World and Science, 29(6),
712-713.
77. Aslani, P., Benrimoj, S. I., & Krass, I. (2006). Development and evaluation of a training program
to foster the use of written drug information in community pharmacies: Part 1 - Development.
Pharmacy Education, 6(1), 41-52.
78. Albrecht, L. C., Roberts, A., Benrimoj, S. I., Williams, K., Chen, T. F., & Aslani, P. (2006).
Cognitive Pharmaceutical Services: Financial Facilitators. Australian Pharmacist, 25(10), 809-
816.
79. Roberts, A. S., Benrimoj, S. I., Chen, T. F., Williams, K. A., & Aslani, P. (2006). Implementing
cognitive services in community pharmacy: A review of facilitators used in practice change.
International Journal of Pharmacy Practice, 14(3), 163-170.
80. Roberts, A. S., Benrimoj, S. I., Chen, T. F., Williams, K. A., & Aslani, P. (2006). Implementing
cognitive services in community pharmacy: A review of models and frameworks for change.
International Journal of Pharmacy Practice, 14(2), 105-113.
81. Puumalainen, I. I., Peura, S. H., Kansanaho, H. M., Benrimoj, S., & Airaksinen, M. S. A. (2005).
Progress in patient counselling practices in Finnish community pharmacies. International Journal
of Pharmacy Practice, 13(2), 149-156.
82. Gastelurrutia, M., Fernandez-Llimos, F., Garcia-Delgado, P., Faus, J., & Benrimoj, S. I. (2005).
Barriers and facilitators to the dissemination and implementation of cognitive services in Spanish
community pharmacies. Seguimiento Farmacoterapeutico, 3(2), 65-77.
83. Roberts, A., Benrimoj, S. I., Chen, T. F., Williams, K., & Aslani, P. (2005). Implementation of
Home Medicines Review (HMR) in Community Pharmacy. Australian Pharmacist, 24(10), 808-
813.
84. Farris, K. B., Fernandez-Llimos, F., & Benrimoj, S. I. (2005). Pharmaceutical care in community
pharmacies: Practice and research from around the world. Annals of Pharmacotherapy, 39(9),
1539-1541.
85. Benrimoj, S. I., & Roberts, A. S. (2005). Providing patient care in community pharmacies in
Australia.. The Annals of pharmacotherapy, 39(11), 1911-1917.
86. Roberts, A. S., Benrimoj, S. I. C., Chen, T. F., Williams, K. A., Hopp, T. R., & Aslani, P. (2005).
Understanding practice change in community pharmacy: A qualitative study in Australia.
Research in Social and Administrative Pharmacy, 1(4), 546-564.
87. Benrimoj, S. I., & Frommer, M. S. (2004). Community pharmacy in Australia. Australian health
review: A publication of the Australian Hospital Association, 28(2), 238-246.
88. Moles, R., Brien, J., & Benrimoj, S. I. (2004). Factors influencing pharmaceutical service
provision within NSW private hospitals. Australian Pharmacist, 23(3), 238-243.
89. Benrimoj, S. I., Langford, J. H., Berry, G., Collins, D., Lauchlan, R., Stewart, K., Ward, P. R.
(2003). Clinical intervention rates in community pharmacy: A randomised trial of the effect of
education and a professional allowance. International Journal of Pharmacy Practice, 11(2), 71-
80.
90. Benrimoj, S. I., Langford, J. H., Berry, G., Collins, D., Lauchlan, R., Stewart, K., Ward, P. R.
(2003). Clinical significance of clinical interventions in community pharmacy: A randomised trial
of the effect of education and a professional allowance. International Journal of Pharmacy
Practice, 11(2), 81-87.
91. Benrimoj, S. I., Peacocke, G., Whitehead, P., Kopecny, E., Ward, P. R., & Emerson, L. (2003).
Cognitive pharmaceutical services in emerging health care systems - New patient medication
17
management and concordance services in community pharmacy. Journal of Social and
Administrative Pharmacy, 20(1), 2-12.
92. Whitehead, P. A., Sunderland, V. B., & Benrimoj, S. I. (2003). The 'general practice' pharmacist.
Australian Journal of Pharmacy, 84(994), 24-27.
93. Roberts, A. S., Hopp, T., Sørensen, E. W., Benrimoj, S. I., Chen, T. F., Herborg, H., Aslani, P.
(2003). Understanding practice change in community pharmacy: A qualitative research
instrument based on organisational theory. Pharmacy World and Science, 25(5), 227-234.
94. Smith, M. A., Simpson, J. M., & Benrimoj, S. I. (2002). General practitioner acceptance of
medication review in Sydney nursing homes. Journal of Pharmacy Practice and Research, 32(3),
227-231.
95. Sigrist, T., Benrimoj, S. I., Hersberger, K., & Langford, J. (2002). Changing pharmacists' and
pharmacist assistants' practice in dealing with direct requests for non-prescription analgesics.
International Journal of Pharmacy Practice, 10(1), 23-29.
96. Chen, T. F., Crampton, M., Krass, I., & Benrimoj, S. I. (2001). Collaboration between community
pharmacists and GPs - Impact on interprofessional communication. Journal of Social and
Administrative Pharmacy, 18(3), 83-90.
97. Benrimoj, C., Langford, J., Christian, J., Charlesworth, A., & Steans, A. (2001). Efficacy and
tolerability of the anti-inflammatory throat lozenge Flurbiprofen 8.75Mg in the treatment of sore
throat - A randomised, double-blind, placebo-controlled study. Clinical Drug Investigation, 21(3),
183-193.
98. De Almeida Neto, A. C., Kelly, F., & Benrimoj, S. I. (2001). Shaping practice behaviour: Novel
training methodology. International Journal of Pharmacy Practice, 9(3), 203-210.
99. De Almeida Neto, A. C., Benrimoj, S. I., Kavanagh, D. J., & Boakes, R. A. (2000). A pharmacy
based protocol and training program for non-prescription analgesics. Journal of Social and
Administrative Pharmacy, 17(3), 183-192.
100. Benrimoj, S. I., Langford, J. H., Berry, G., Collins, D., Lauchlan, R., Stewart, K., Dobson, M.
(2000). Economic impact of increased clinical intervention rates in community pharmacy: A
randomised trial of the effect of education and a professional allowance. PharmacoEconomics,
18(5), 459-468.
101. De Almeida Neto, A. C., Benrimoj, S. I., Kavanagh, D. J., & Boakes, R. A. (2000). Novel
educational training program for community pharmacists. American Journal of Pharmaceutical
Education, 64(3), 302-307.
102. Whitehead, P., Atken, P., Krass, I., & Benrimoj, S. I. (1999). Patient drug information and
consumer choice of pharmacy. International Journal of Pharmacy Practice, 7(2), 71-79.
103. Aslani, P., Benrimoj, S. I., & Krass, I. (1999). An Evaluation of Two Interventions for the
Use of Consumer Medicine Information by Community Pharmacists. Journal of Social and
Administrative Pharmacy, 16(2), 88-89.
104. Chen, T. F., Crampton, M., Krass, I., & Benrimoj, S. I. (1999). Collaboration between
community pharmacists and GPs - The medication review process. Journal of Social and
Administrative Pharmacy, 16(3-4), 145-156.
105. Chen, T. F., Crampton, M., Krass, I., & Benrimoj, S. I. (1999). Collaboration between
community pharmacists and GPs in innovative clinical services - A conceptual model. Journal of
Social and Administrative Pharmacy, 16(3-4), 134-144.
106. Kelly, F. S., & Benrimoj, S. I. (1999). Evaluation of the Impact of a Protocol Training
Program on Pharmacy Assistant Non-Prescription Medication Supply to Consumers. Journal of
Social and Administrative Pharmacy, 16(2), 85-86.
107. Roins, S., Benrimoj, S. I., Carroll, P. R., & Johnson, L. W. (1999). Pharmacist
Recommendation of Nonprescription Analgesics: A Test of Nested versus Nonnested Decision-
Making Structure. Journal of Pharmaceutical Marketing & Management, 13(2), 27-47.
108. Roins, S., Benrimoj, S. I., Carroll, P. R., & Johnson, L. W. (1999). Pharmacists' Brand
Recommendations of Nonprescription Analgesics for a Simple, Tension, and Migraine Headache.
Journal of Pharmaceutical Marketing & Management, 13(1), 27-49.
109. Aslani, P., Benrimoj, S. I., & Krass, I. (1999). The Development and Implementation of Two
Interventions for the Use of Consumer Medicine Information by Community Pharmacists.
Journal of Social and Administrative Pharmacy, 16(2), 74-75.
18
110. Roins, S., Benrimoj, S. I., Carroll, P. R., & Johnson, L. W. (1998). Factors used by
pharmacists in the recommendation of the active ingredient(s) and brand of non-prescription
analgesics for a simple, tension and migraine headache. International Journal of Pharmacy
Practice, 6(4), 196-206.
111. Chen, T., Casson, C., Krass, I., & Benrimoj, S. I. (1998). Medication Reiew: A process guide
for community pharmacists. Australian Pharmacist, 15, 681-686.
112. Benrimoj, S. I., Roins, S., Carroll, P., & Johnson, L. (1998). Pharmacists Evaluation of
an adult with headache and the nonprescription analgesics recommended. Australian Pharmacist,
17(8), 21-27.
113. Roins, S., Benrimoj, S. I., Carroll, P., & Johnson, L. (1998). Pharmacists' recommendation of
the active ingredient(s) of Non-Prescription Analgesics for a simple, tension and migraine
headache. Australian Pharmacist, 15(4), 262-274.
114. Benrimoj, S. I., Langford, J. H., & O'Brien, J. A. (1998). Switch on to a Schedule change.
Australian Journal of Pharmacy, 79(936), 302.
115. Aslani, P., Benrimoj, S. I., & Krass, I. (1998). Use of CMI by NSW Community pharmacists:
A baseline Study. Australian Pharmacist, 17(8), 15-20.
116. Langford, J. H., & Benrimoj, S. I. (1997). Clinical investigation of topical antimicrobials in
healthy volunteers. Annals of Pharmacotherapy, 31(1), 34-38.
117. Langford, J. H., Artemi, P., & Benrimoj, S. I. (1997). Topical antimicrobial prophylaxis in
minor wounds. Annals of Pharmacotherapy, 31(5), 559-563.
118. Caleo, S., Benrimoj, S., Collins, D., Lauchlan, R., & Stewart, K. (1996). Clinical evaluation
of community pharmacists' interventions. International Journal of Pharmacy Practice, 4(4), 221-
227.
119. Hannaoui, A., Krass, I., & Benrimoj, S. I. (1996). Review of computerised patient medication
records to determine potential clinical interventions in community pharmacy. International
Journal of Pharmacy Practice, 4(3), 162-167.
120. Langford, J. H., & Benrimoj, S. I. (1996). Clinical rationale for topical antimicrobial
preparations. Journal of Antimicrobial Chemotherapy, 37(3), 399-402.
121. De Almeida Neto, A. C., Benrimoj, S. I., Gomel, M., & Fois, R. (1996). Inappropriate self-
medication practices: A pharmacy-based intervention. Journal of Social and Administrative
Pharmacy, 13(3), 131-138.
122. Chen, T. F., Casson, C., Krass, I., & Benrimoj, S. I. (1996). Medication Regimen Review
Process: A Guide for Community Pharmacists. Australian Pharmacist, 15(11), 681-686.
123. Caleo, S., Benrimoj, S. I., Collins, D., Hall, J., Lauchlan, R., & Stewart, K. (1996).
Pharmacists' Clinical Interventions: A Cost Analysis. Australian Pharmacist, 15(3), 143-148.
124. Williams, K., & Benrimoj, S. I. (1996). Pharmacoepidemiological studies of non-prescription
products. Australian Journal of Pharmacy, 77, 184.
125. Carr, R., & Benrimoj, S. I. (1996). Professional services in community pharmacy. Australian
Pharmacist, 15(8), 467-468.
126. Benrimoj, S. I., Thornton, P., & Langford, J. (1995). A Review of Drug Distribution Systems:
Part 1 - Current Practice. Australian Journal of Hospital Pharmacy, 25(2), 119-126.
127. Benrimoj, S. I., Thornton, P. D., & Langford, J. H. (1995). A review of drug distribution
systems: Part 2 - Automated dispensing for unit dose systems. Australian Journal of Hospital
Pharmacy, 25(3), 230-235.
128. Bowden, M., & Benrimoj, S. I. (1995). Pharmacists' Attitudes toward the Switch from Rx to
OTC: The Australian Situation. Journal of Pharmaceutical Marketing & Management, 10(1), 29-
43.
129. Benrimoj, S. I., Langford, J. H., Bowden, M. G., & Triggs, E. J. (1995). Switching drug
availability from prescription only to over-the-counter status. Are elderly patients at increased
risk?. Drugs & aging, 7(4), 255-265.
130. Emmerton, L., Gow, D., & Benrimoj, S. (1994). Dimensions of pharmacists' preferences for
cough and cold products. International Journal of Pharmacy Practice, 3(1), 27-32.
131. Roins, S., Benrimoj, S. I., & Carroll, P. (1994). Factors Affecting Pharmacists' Choice of
Nonprescription Analgesics. Journal of Pharmaceutical Marketing & Management, 9(1), 3-18.
19
132. Emmerton, L., & Benrimoj, S. I. (1994). Factors influencing pharmacists' preferences for non-
prescription cough suppressants. Journal of Social and Administrative Pharmacy, 11(2), 78-85.
133. Booth, J. H., Benrimoj, S. I., & Nimmo, G. R. (1994). In vitro interactions of neomycin
sulfate, bacitracin, and polymyxin B sulfate. International Journal of Dermatology, 33(7), 517-
520.
134. Roins, S., Benrimoj, S. I., & Carroll, P. (1994). Nonprescription analgesics pharmacists
recommend for various pain conditions. Australian Pharmacist, 13(10), 670-675.
135. Emmerton, L., & Benrimoj, S. I. (1994). Product selection by pharmacists and medical
practitioners: A review of methods and models. Journal of Social and Administrative Pharmacy,
11(1), 46-53.
136. Bowden, M., & Benrimoj, S. I. (1994). Proposals for ammending the criteria for transferring
medicines from prescription to non-prescription. Australian Pharmacist, 13(8), 519-525.
137. Benrimoj, S. I. (1993). Analysis of the Australian National Formulary Survey. Australian
Prescriber, 16, 21-24.
138. Gattera, J., Stewart, K., & Benrimoj, S. I. (1992). A review of non-prescription medication
and diabetes mellitus. Australian Pharmacist, 11, 231-237.
139. Gattera, J., Stewart, K., & Benrimoj, S. I. (1992). Minor health problems and people with
diabetes. Australian Pharmacist, 11, 140-145.
140. Booth, J. H., & Benrimoj, S. I. (1992). Mupirocin in the treatment of impetigo. International
Journal of Dermatology, 31(1), 1-9.
141. Gattera, J. A., Stewart, K., Benrimoj, S. I., & Williams, G. M. (1992). Usage of non-
prescription medication by people with diabetes. Journal of Social and Administrative Pharmacy,
9(2), 66-74.
142. Chua, S. S., Benrimoj, S. I., Gordon, R. D., & Williams, G. (1991). Cardiovascular effects of
a chlorpheniramine/paracetamol combination in hypertensive patients who were sensitive to the
pressor effect of pseudoephedrine. British Journal of Clinical Pharmacology, 31(3), 360-362.
143. Emmerton, L., & Benrimoj, S. I. (1991). Influences on Pharmacists' Stocking and
Recommendation of Nonprescription Products. Journal of Pharmaceutical Marketing &
Management, 5(3), 37-50.
144. Benrimoj, S. I., & Bowden, M. (1991). The switch of medicines from prescription to non-
prescription: A survey of community pharmacists - Preliminary results. Australian Pharmacist,
10, 211-214.
145. Chua, S. -S., Benrimoj, S. I., Stewart, K., & Williams, G. (1991). Usage of non-prescription
medications by hypertensive patients. Journal of Social and Administrative Pharmacy, 8(1), 33-
45.
146. Benrimoj, S. I., & Chua, S. (1990). Minor health problems and hypertensive patients.
Australian Pharmacist, 9, 150-154.
147. Benrimoj, S. I., & Chua, S. (1990). Predictors of use for non-prescription medication. Journal
of Pharmaceutical Marketing and Management, 5, 3-27.
148. Chua, S. S., Benrimoj, S. I., Gordon, R. D., & Williams, G. (1989). A controlled clinical trial
on the cardiovascular effects of single doses of pseudoephedrine in hypertensive patients. British
Journal of Clinical Pharmacology, 28(3), 369-372.
149. Emmerton, L. M., & Benrimoj, S. I. (1989). Influences on pharmacists' recommendation of
non-prescription products. Australian Journal of Pharmacy, 70, 594-597.
150. Chua, S. S., Benrimoj, S. I., & Trigss, E. J. (1989). Pharmacokinetics of non-prescription
sympathomimetic agents. Biopharmaceutics and Drug Disposition, 10(1), 1-14.
151. Benrimoj, S. I. (1988). Non-Prescription medicines respiratory tract. International Journal of
Medicine and Pharmacy, 10(1), 15-17.
152. Chua, S. S., & Benrimoj, S. I. (1988). Non-prescription sympathomimetic agents and
hypertension. Medical Toxicology and Adverse Drug Experience, 3(5), 387-417.
153. Moshovelis, J., Benrimoj, S. I., Craig, M., Low, J., & Just, D. (1987). Dispensing times pre
and post computerisation. Australian Journal of Hospital Pharmacy, 17, 105-108.
154. Kastrissios, H., Chua, S., & Benrimoj, S. I. (1987). Non-prescription oral sympathomimetic
amines and the common cold. Australian Pharmacist, 6, 26-28.
20
155. Davis, P. G., Benrimoj, S. I., & Wright, A. H. (1987). Outpatient pharmaceutical services:
Impact of international trends on Australia. Australian Journal of Hospital Pharmacy, 17(4), 272-
276.
156. Stewart, K., & Benrimoj, S. I. (1987). Specialised Services from Community Pharmacy.
Journal of Pharmaceutical Marketing & Management, 2(1), 147-158.
157. Boreham, P., & Benrimoj, S. I. (1986). A compliance study in paediatric patients receiving
treatment for Giardiasis. Australian Journal of Hospital Pharmacy, 16, 138-142.
158. Benrimoj, S. I., & Robinson, M. T. (1986). Analysis and guidelines for the selection of Over-
the-counter (OTC) respiratory tract products. Australian Journal of Pharmacy, 67, 875-880.
159. Benrimoj, S. I., & Reisenwitz, T. H. (1986). Consumer satisfaction with over-the-counter
products in pharmacy and non-pharmacy students.. Journal of pharmaceutical marketing &
management, 1(1), 69-76.
160. Benrimoj, S. I., & Stewart, K. (1986). Diabetic services from community pharmacy.
Pharmaceutical Journal, 237, 805.
161. Stewart, K., Garde, T. W., & Benrimoj, S. I. (1986). Over-the-counter medication sales in
community pharmacy: Part B - Consumer aspects. Australian Journal of Pharmacy, 67, 270-272.
162. Stewart, K., Benrimoj, S. I., & Wright, A. H. (1986). Pharmaceutical benefits dispensing -
Views on renumeration. Australian Journal of Pharmacy, 67, 435-436.
163. Benrimoj, S. I. (1985). A look at O.T.C. buying habits. Pharmaceutical Technology, 9, 24-25.
164. Craig, M. L., & Benrimoj, S. I. (1985). Benefits and applications of hospital pharmacy
computer systems. Impressions based on a literature survey. Australian Journal of Hospital
Pharmacy, 15(1).
165. Benrimoj, S. I., Stewart, K., & Garde, T. W. (1985). Over-the-counter medication sales in
community pharmacy. A. Direct product requests and symptom presentation. Australian Journal
of Pharmacy, 66, 979-982.
166. Benrimoj, S. I., & Robinson, M. (1985). Respiratory tract presentations in community
pharmacy. International Journal of Medicine and Pharmacy, 7, 16-18.
167. Smith, M., Benrimoj, S. I., & Stewart, K. (1985). What England and Australia can teach us
about a third class of drugs. Pharmaceutical Executive, 5, 40-42.
168. Benrimoj, C., & Ong, M. M. (1984). Evaluation of the Professional Pharmacy (Pc302) course
at the University of Queensland. American Journal of Pharmaceutical Education, 48(2), 179-183.
169. Preston, J. M., Benrimoj, S. I., & Barnes, A. (1984). Survey of pharmacy openings and
closures in Queensland financial year, 1981-1982. 2. Distribution and competitive environment.
Australian Journal of Pharmacy, 65, 414-418.
170. Preston, J. M., Benrimoj, S. I., & Barnes, A. (1984). Survey of pharmacy openings and
closures in Queensland financial year, 1981-1982. 3. Pharmacy and Proprietor characteristics.
Australian Journal of Pharmacy, 65, 582-584.
171. Benrimoj, S. I. (1983). Counter prescribing communication - Interview structure and content.
International Journal of Medicine and Pharmacy, 5, 12-13.
172. Benrimoj, S. I. (1983). Education for the practice of the profession. International Journal of
Medicine and Pharmacy, 5, 18-19.
173. Preston, J. M., Benrimoj, S. I., & Barnes, A. (1983). Survey of pharmacy openings and
closures in Queensland financial year, 1981-1982. 1. Introduction and methodology. Australian
Journal of Pharmacy, 64, 833-836.
174. Benrimoj, S. I. (1982). A study of counselling events associated with the dispensing service in
four selected community pharmacies. Australian Journal of Pharmacy, 63, 497-500.
175. Preston, J. M., & Benrimoj, S. I. (1982). An analysis of a system controlling the approval to
supply Pharmaceutical Benefits at the state level. Australian Journal of Pharmacy, 63, 745-747.
176. Benrimoj, S. I., Mitchell, I. B., & Wright, A. (1981). The development of a professional
Pharmacy course at the University of Queensland. Australian Journal of Pharmacy, 62, 876-881.
177. Benrimoj, S. I., Booth, T. G., & Jones, I. F. (1980). Some extrapolations and pharmaceutical
implications. Pharmaceutical Journal, 225, 442.
178. Benrimoj, S. I., Booth, T. G., & Jones, I. F. (1978). Analysis and prognosis for health centres
and associated Pharmaceutical Departments. Pharmaceutical Journal, 221, 330-331.
21
10. RESEARCH GRANTS SUMMARY UPDATED TO 2013 (sole or chief investigator only)
Year Number of Grants Total $
2013 2 120,000 +480,000 Euros
2012 2 100,000
2010/2011 2 120,000 Euros
2008/2009 3 222,837.00
2007 3 428,677
2006 2 384,195
2005 3 545,591
2004 6 1,489,136
2003 6 557,708
2002 8 686,782
2001 3 487,282
2000 3 435,000
1999 5 255,807
1998 4 312,082
1997 5 339,832
1996 7 529,342
1995 3 136,905
1994 8 284,577
1993 10 347,992
1992 7 269,781
Total 92 7,9000 +600,000 Euros
11. RESEARCH SUPPORT - FUNDS AND SOURCE UPDATED TO 2012
TITLE Period FUND-
ING SOURCE
Identify a best practice model for the
integration of community pharmacists
in the primary health care setting.
2011-2012 1,500,000 Price Waterhouse Coopers, Pharmacy Guild of
Australia and Department of Health
Clinical, economic and humanistic
impact of medication review with
follow up on elderly patients with poly-
pharmacy ( program conSIGUE)
2010-2012 120,000
Euros College of Pharmacy spain
Pharmacist intervention of Asthma 2010-2011 50,000
Euros AstraZeneca Spain
National trial to test strategies to
improve medication compliance in a
community pharmacy setting.
2008-2009 68,725 Price Waterhouse Coopers, Pharmacy Guild of
Australia and Department of Health
Community pharmacy research into
treatment for opioid dependency 2008-2009 11,275
Price Waterhouse Coopers, Pharmacy Guild of
Australia and Department of Health
22
TITLE Period FUND-
ING SOURCE
Building Organisational Flexibility to
Promote the Implementation of
Primary Care Services in Community
Pharmacy
2008 197244
Pharmacy Guild of Australia and Department of
Health and Aged Care
Quality Care Pharmacy Practice
Center 2002-2008 1112856
Pharmacy Guild of Australia and Department of
Health and Aged Care
Establishment of the Pharmaceutical
International Network 2004-2008 119400
Pharmacy Guild of Australia and Department of
Health and Aged Care
Review of Standards for the Provision
of Pharmacy Only and Pharmacy
Medicines in Community Pharmacy
2005 48500 Pharmacy Guild of Australia and Department of
Health and Aged Care
The Value of Pharmacist Professional
Services in the Community Setting
2002 -
2005 39000
Pharmacy Guild of Australia and Department of
Health and Aged Care
Change Management and Community
Pharmacy 2004 900000
Pharmacy Guild of Australia and Department of
Health and Aged Care
A quantitative analysis of business and
professional facilitators for change for
the pharmacy profession in light of the
Third Guild/Government Agreement
2004 65000 Pharmacy Guild of Australia and Department of
Health and Aged Care
Professional pharmacy services to
private hospitals 2002-2003 76593
Pharmacy Guild of Australia and Department of
Health and Aged Care
An investigation into business and
professional facilitators for change for
the pharmacy profession in light of the
Third Guild/Government Agreement
2002-2003 81677 Pharmacy Guild of Australia and Department of
Health and Aged Care
Cost benefit analysis of the S2/S3
medicines and risk based evaluation of
the standards
2002-2004 812180 Pharmacy Guild of Australia and Department of
Health and Aged Care
Case conferencing and care planning :
collaboration between community
pharmacists and GP’s
2002 86737 Pharmacy Guild of Australia and Department of
Health and Aged Care
Novel methods of quantifying pain and
inflammation to assess efficacy of
over-the-counter medicines
2000-2002 144000 ARC_SPIRT (Boots)
A system to help community health
care teams facilitate quality use of
medicines in rural and remote areas
2001-2003 246845 Office of Rural Health, Department of Health and
Aged Care
Implementation mechanism to raise
standards of practice re supply of
pharmacy & pharmacist only
medicines in Community Pharmacy
2000-2001 714000 Commonwealth Department of Health and
Family Services
Investigate current level of use of the
sale of medicines Protocol 2000 30000 Boots the Chemist, England
Tele pharmacy 1999 25000 Pharmacy Practice Foundation
Implementation of a preventative
primary health care model in
community pharmacy
1999 49500 Astra Pharmaceutical
A novel approach for differentiating
between effective and ineffective sore
throat medications
1998-1999 168500 ARC-SPIRT/Boots
23
TITLE Period FUND-
ING SOURCE
Best pharmacy practice for alternative
pharmacy arrangements 1997-1999 143421
Commonwealth Department of Health and
Family Services
Standards of practice for pharmacists
only and pharmacy medicines 1997-1998 198550
Commonwealth Department of Health and
Family Services
Initiative for treating and counselling
heartburn and indigestion sufferers
(SWITCH)
1997 26000 Warner Lambert
Pharmacists interventions study 1996 69221 Marion Merrell Dow
Development of professional services 1996 62000 API Healthcare
Financial benefits to community
pharmacists arising from the delivery
of patient drug information
1996 35000 Micromedex
Flurbiprofen lozenge study 1996 97500 Boots Healthcare
Pharmacists behaviour change pilot
study 1996 42900 Amrad
A randomised trial on the effect of
education and a professional allowance
on clinical intervention rates in
pharmacy: clinical and cost benefit
evaluation
1996-1997 263000 Commonwealth Department of Health and
Family Services
Pharmacy study of use of non-
prescription analagesics in community
pharmacy
1996-1999 256471 Hoechst Marion Roussel
Medicine regimen reviews - A
collaborative project between
community pharmacists and general
practitioners
1994-1995 114850 PHARM
Pharmacoepidemiological study of
non-prescription analgesics 1993-1995 112400 Marion Merrell Dow
Feasibility study of unit dose
automated dispensing systems 1993 50000 Department of Health, NSW Government
An economic analysis of pharmacist
interventions associated with
Pharmaceutical Benefits System. Part
1 - feasibility study
1993-1994 13800 Australian Pharmacy Research Centre
Pharmacy practice under-graduate and
research forum 1993 9800 Boots Pharmaceutical Pty Ltd
Establishment of a pharmacy practice
undergraduate laboratory 1992 72270 Various sources
Delivery of professional services in the
prescription area 1992-1995 233440 Australian Pharmaceutical Industries
Topical preparations 1992-1994 124000 Upjohn Pty Ltd
Clinical and marketing aspects of
primary dysmenorrhoea 1992-1994 42000
Reckitt and Colman (Pharmacy Practice
Foundation)
Determinants of choice by pharmacists
of non-prescription analgesics 1992-1994 30000 Sterling (Pharmacy Practice Foundation)
Marketing strategies of non-
prescription medication 1992-1993 55138 Upjohn Pty Ltd
Research and development of a
pharmacy educational program 1992-1994 57357
Continuing and Professional Education
Department, University of Queensland
12. RESEARCH GRANTS PRIOR TO 1992
24
TITLE INVESTIGATORS PERIOD SOURCE
Evaluation of Med-Aware programme S. Benrimoj
K. Stewart
1991 Pharmaceutical Society of
Australia
Review of OTC regulatory affairs S. Benrimoj 1990 Therapeutic Goods
Administration
Topical antibiotics S. Benrimoj
J. Booth
1990 Upjohn Pty Ltd
Rescheduling - marketing surveillance
systems
S. Benrimoj
M. Bowden
1990 NHMRC
Marketing aspects of non-prescription
medication
S. Benrimoj
S. Hocart
1990 Upjohn Pty Ltd
National tracking service for non-prescription
sales
S. Benrimoj
M. Robinson
1989 The Medicine Group
Transfer of prescription to non-prescription
status
S. Benrimoj
M. Bowden
1989 Qld Pharmacy Trust
Non-prescription medication usage in
hypertensive patients
S. Benrimoj
S. Chua
1988 Qld Pharmacy Trust
Factors affecting selection of non-prescription
medications
S. Benrimoj
L. Emmerton
1988 Reckitt and Colman
Non-prescription medication usage in diabetic
patients
S. Benrimoj
K. Stewart
1988 Qld Pharmacy Trust
Non-prescription medications consumer
survey
S. Benrimoj
K. Stewart
M. Robinson
1987 The Medicine Group
Diabetic services from community pharmacy K. Stewart
S. Benrimoj
1986 Qld Pharmacy Trust
Clinical trial of non-prescription drugs S. Benrimoj
S. Chua
A. Gordon
1986 Reckitt and Colman
Educational video on skin products S. Benrimoj
I.B. Mitchell
1986 Qld Pharmacy Guild
Retail strategies in community pharmacy S. Benrimoj
I.B. Mitchell
1986 Qld Druggists Ltd.
O.T.C. vitamin sales in community pharmacy S. Benrimoj
M. Robinson
1986 Roche Pty Ltd
Community pharmacist placement scheme S. Benrimoj
K. Stewart
I.B. Mitchell
A.H. Wright
1985 T.E.D.I.
25
TITLE INVESTIGATORS PERIOD SOURCE
Non-prescription drug development S. Benrimoj 1985 Reckitt and Colman
O.T.C. ibuprofen - drug utilisation study S. Benrimoj
M. Smith
1985 Marion Inc. (USA)
Registration procedures for non-prescription
drugs
S. Benrimoj
I.B. Mitchell
1984 Ciba-Geigy
Pharmaceutical services in community
pharmacy
S. Benrimoj
K. Stewart
A.H. Wright
1984 Qld Pharmacy Trust
Pharmacy practice research methods for
practising pharmacists
S. Benrimoj 1984 Pharmaceutical Society of
Australia
Pharmacists' guide to proprietary product
schedules
S. Benrimoj
A.H. Wright
1984 Qld Pharmacy Guild
Development of a computer data base for drug
information in community pharmacy
M. Robinson
S. Benrimoj
1983 Qld Pharmacy Trust
Teaching development grants S. Benrimoj
A.H. Wright
I.B. Mitchell
1982/84 T.E.D.I.
Construction of a simulated community
pharmacy environment
S. Benrimoj 1982 Qld Pharmacy Trust
O.T.C. medication survey K. Stewart
T. Garde
S. Benrimoj
1982 Ciba-Geigy
Survey of pharmacy openings and closures in
Qld, 1981-1982
J. Preston
S. Benrimoj
1982 Qld Pharmacy Guild
Audio visual equipment S. Benrimoj 1981 Qld Pharmacy Trust
26
13. SCIENTIFIC COMMUNICATIONS 1. Malet-Larrea, A., Goyenechea, E., Gastelurrutia, M.A., Martinez-Martinez, F., Calvo, B. &
Benrimoj, S.I. Hospital Admissions associated with Medications in elderly patients. Sociedad
Espanola De Farmacia industrial Y Galencia, 2015. Barcelona, Spain.
2. Moullin, J., Benrimoj, S.I. Preliminary Evaluation the Framework for the implementation of
Services in Pharmacy. 74th International Congress of FIP, 2014. Bangkok, Thailand. 3. Garcia-Cardenas, V., Benrimoj, S.I. Medical Practitioners’ acceptance rate of pharmacist
recommendation arising from a medication review with follow up (MRF) in ambulatory aged
patients in Spain: conSIGUE Program. 74th International Congress of FIP, 2014. Bangkok,
Thailand. 4. Garcia-Cardenas, V., Benrimoj, S.I. Costs and setting of professional fee for a medication review
with follow up (MRF) in ambulatory aged patients in community pharmacy in Spain: conSIGUE
Program. 74th International Congress of FIP, 2014. Bangkok, Thailand.
5. Benrimoj, S.I. Cost-Utility Analysis of a medication review with follow-up for older
people with polypharmacy in community pharmacies in Spain: conSIGUE Program.
ISPOR 17th
Annual European Congress, 2014, Amsterdam, Netherlands. 6. Salgado TM, Arguello B, Martinez-Martinez F, Benrimoj SI, Fernandez-Llimos F. Is information
for dose adjustment in renal impairment contained in Summaries of Product Characteristics
suitable for integration in clinical decision support systems? 42nd ESCP Symposium 2013. Prague,
Czech Republic.
7. Larrañaga B, Goyenechea E, Varas R, Martinez F, Benrimoj SI, Gastulerritia MA. Primas
resultados del programa conSIGUE en Gipuzkoa “Preliminary results of the ConSIGUE Program
in Gipuzkoa”. Congreso Nacional de Farmacéuticos Comunitarios, 2012. Barcelona, Spain.
8. Salgado TM, Arguello B, Benrimoj SI, Fernandez-Llimos F. Discordances in the Classification of
Renal Impairment in Summaries of Product Characteristics. ERA-EDTA 2012. Paris, France.
9. Salgado TM, Ramos SB, Clesia S, Canas R, Cunha I, Benrimoj SI, Fernandez-Llimos F. Utility of
the Newest Vital Sign to assess health literacy in community-dwelling older adults. 41st ESCP
Symposium 2012. Barcelona, Spain.
10. Goyenechea E, Malet A, Larrañaga B, Varas R, Sáez-Benito L, Martinez-martinez F,
Gastelurrutia MA, Berimoj SI, Garay A. Program ConSIGUE Initial Results of Main Study in
Provence of Gipulzka. XVIII Congreso Nacional Farmaceutico. 2011. Santander, Spain.
11. Salgado T.M., Moles, R., Benrimoj, S.I., Fernandez-llimos, F. Potential future involvement of
pharmacists in outpatient dialysis clinics: a qualitative study. XVII European Association of
Faculties of Pharmacy Annual Congress, 2011 Lisbon, Portugal.
12. Salgado T.M., Moles, R., Benrimoj, S.I., Fernandez-llimos, F. Opinions towards the
implementation of a pharmacy service in outpatient haemodialysis centres. IV Conferencia Ibero-
americana de Facultades de Farmacia (COIFFA) 2011 Lisbon, Portugal.
13. Gil M.I., Feletto F., Benrimoj S.I., Martinez-Martinez F, Calvo B., Gastelurrutia M.A. Análisis
factorial para la priorización de facilitadores para la implantación del seguimiento
farmacoterapeutico en las farmacias Españolas . IV Conferencia Ibero-americana de Facultades de
Farmacia (COIFFA) 2011 Lisbon, Portugal.
14. Salgado T.M., Moles R., Benrimoj S.I., Fernandez-llimos F. The role of pharmacists in the
management of chronic disease patients; a qualitative study. 11th Working Conference PCNE ,
Manchester, London
15. Sáez-Benito L, Benrimoj SI, Feletto E, García-Cárdenas V, Gastelurrutia MA. Evaluación del
impacto del Seguimiento Farmacoterapéutico en el numero de medicamentos de los pacientes
mayores polimedicados en el estudio piloto del programa consigue. 2010, SEFAC, Valencia,
España.
16. Benrimoj SI, Feletto E, Gastelurrutia MA, Jodar Sánchez F, Sáez-Benito L, Martínez-Martínez
F. Evaluación del coste efectividad del Seguimiento Farmacoterapéutico a los pacientes
mayores polimedicados en el estudio piloto del programa consigue. 2010, SEFAC, Valencia,
España.
27
17. Sáez-Benito L, Benrimoj SI, Faus Dáder MJ, Feletto E, García-Cárdenas V, Gastelurrutia MA.
Evaluación del impacto del Seguimiento Farmacoterapéutico en el control de los problemas de
salud de los pacientes mayores polimedicados en el estudio piloto del programa consigue. 2010,
SEFAC, Valencia, España.
18. Benrimoj SI, Gastelurrutia MA, Feletto E, Sáez-Benito L, Varas Doval R, García-Cárdenas V,
Martínez-Martínez F, Faus Dáder MJ. consigue: medida del impacto clínico, económico y
humanístico del Seguimiento Farmacoterapeutico en mayores polimedicados. Estudio piloto. 17
Congresos Nacional Farmacéutico, 2010, Bilbao, España.
19. García-Cárdenas V, Feletto E, Bimbela JL, Benrimoj SI., Faus Dáder MJ (2010) Programa
conSIGUE: Formadores Colegiales. Una innovación para implantar servicios de Atención
Farmacéutica en las farmacias comunitarias. 17 Congresos Nacional Farmacéutico, 2010,
Bilbao, España.
20. Martínez-Martínez F, Faus Dáder MJ, Feletto E, Gastelurrutia MA, Sáez-Benito L, Varas
Doval R, Benrimoj SI. El coste-efectividad del Seguimiento Farmacoterapeutico en farmacias
comunitarias españolas (Programa conSIGUE) XIV Congreso Internacional de OFIL
(Farmacéutico Ibero Latinoamericano), 2010, Chile.
21. Martínez-Martínez F, Faus Dáder MJ, Feletto E, Gastelurrutia MA, Sáez-Benito L, Varas
Doval R, Benrimoj SI. El coste-efectividad del Seguimiento Farmacoterapeutico en farmacias
comunitarias españolas (Programa conSIGUE) XIV Congreso Internacional de OFIL
(Farmacéutico Ibero Latinoamericano), 2010, Chile
22. García-Cárdenas V, Bimbela JL, Faus Dáder MJ, , Gastelurrutia MA, Martínez-Martínez F,
Sáez-Benito L, Benrimoj SI (2010) Desarrollo del formador colegial: Apoyo para la
implantación de servicios cognitivos en el ámbito de la farmacia comunitaria (PROGRAMA
conSIGUE) XIV Congreso Internacional de OFIL (Farmacéutico Ibero Latinoamericano), Chile
23. Feletto et al. Measuring capacity in community pharmacy using organizational flexibility. 16th
ISPW 2010 Lisbon, Portugal
24. Feletto et al. Building capacity in Australian community pharmacies: an educational workshop.
16th ISPW 2010, Lisbon, Portugal
25. Sáez-Benito L et al. Evaluating the clinical impact of pharmacotherapy follow up on geriatric poly
pharmacy patients’ health: a pre-pilot. 16th ISPW 2010, Lisbon, Portugal
26. Feyer AM et al. Improving medication compliance. Pharmacy Practice Research Summit 2010,
Canberra
27. Feletto E, Benrimoj SI. Building the Capacity of community pharmacy to implement services.
Pharmacy Practice Research Summit 2010, Canberra
28. Feletto E, Wilson LK, Benrimoj SI. Building the capacity to implement services: Emerging
business models in community pharmacy. Pharmacy Practice Research Summit 2010, Canberra
29. Feletto E, Benrimoj SI. Building the Capacity of community pharmacy using organizational
flexibility. Pharmacy Practice Research Summit 2010, Canberra.
30. Garcia-Cardenas V, Feletto E, Fernandez-Galdon RP, Nava-Vargas EM, Martinez-Martinez F,
Benrimoj S. [Formacion de formadores colegiles. Programa conSIGUE. Simpodader (2009),
Girona, Spain. Arspharmaceutica 2010, 51, 71. ISSN:0004-2927.
31. Garcia-Cardenas V, Benrimoj SI, Chemello C, Arrillaga A, Faus MJ. [Efecto de una intervención
farmacéutica sobre el grado de control del paciente asmático. Estudio piloto Simpodader (2009),
Girona, Spain. Arspharmaceutica 2010, 51, 64. ISSN:0004-2927.
32. Saez-Benito L, Faus Dader MJ, Feletto E, Fernandez-Llimos Somoza F, Plaza C, Benrimoj SI,
[Propuesta de indicadores de proceso y descripción del seguimiento farmacoterapeutico en el pre-
piloto de investigación del Programa conSIGUE, Simpodader (2009), Girona, Spain.
Arspharmaceutica 2010, 51, 75. ISSN:0004-2927.
33. Noain MA, Feletto E, Gastelurrutia MA, Benrimoj SI. [Rentabilidad de la prestación de servicios
profesionales en la farmacia comunitaria española]. Simpodader (2009), Girona, Spain.
Arspharmaceutica 2010, 51, 76. ISSN:0004-2927.
34. Sabater-Galindo M, Benrimoj S, Feletto E, Faus MJ, Gastelurrutia MA.[Teorías de cambio de
comportamiento en los farmacéuticos y los pacientes y sus aplicaciones] Simpodader (2009),
Girona, Spain. Arspharmaceutica 2010, 51, 78. ISSN:0004-2927.
28
35. Feletto, E., Wilson, L. K., Roberts, A. S., Benrimoj, S. I. Strategies for Sustaining Pharmaceutical
Care Services (PCS) in Australian Community Pharmacies. Pharmaceutical Care Network of
Europe Conference (2009), Vimiero, Portugal.
36. Feletto, E., Wilson, L. K., Roberts, A. S., Benrimoj, S. I. The Development of a Tool to Measure
Community Pharmacy’s Capacity for Implementing Pharmaceutical Care Services. Pharmaceutical
Care Network of Europe Conference (2009), Vimiero, Portugal.
37. Feletto,E. A.P.S.A., Canberra, 2008. A Qualitative Investigation of Organisation Flexibility in
Australian Community Pharmacies (co-author).
38. Benrimoj, S.I. Werner, J.B. Comparative analysis of pharmacy assist/pharmacy practice behaviour
during the provision of non-prescription medications. 68th Congress of FIP (2008), Basel
Switzerland.
39. Feletto, E., Roberts, A., Benrimoj, S.I. Optimising Business Viability in Community Pharmacy:
An Organisational Flexibility Framework. 15th International Social Pharmacy Workshop 2008,
Queenstown, New Zealand.
40. Benrimoj, S.I., O’Reilly, C., Chen, T. Exploring Health Care Professionals’ Views on the Role of
Pharmacists Within Community Mental Health: A Work in Progress. 68th Congress of FIP 2008,
Basel, Switzerland.
41. Benrimoj, S.I., Feletto, E., Roberts, A. A Qualitative Investigation of Organisational Flexibility in
Australian Community Pharmacies: Work in Progress. 68th Congress of FIP 2008, Basel,
Switzerland.
42. Benrimoj, S.I., Krass, I., Emerson, L. An inter-disciplinary continuous quality improvement (CQI)
approach to improving cardiovascular risk in rural Australia. 15th International Social Pharmacy
Workshop (2008), Queensland, New Zealand.
43. Benrimoj, S.I., Feletto, E., Costa, F., Fernandez-Limon, F., Oller Dolcet, H., Roberts, A. Applying
Organisational Flexibility to Community Pharmacy – An International Qualitative Study of
Pharmacy Business Models and Strategies. Annual Conference of the Australasian Pharmaceutical
Science Association (2007), Sydney, Australia.
44. Benrimoj, S.I., Oller Dolcet, H, Feletto, E., Costa, F., Roberts, A., Fernandez-Limos, F.
Organizational Flexibility in Community Pharmacy: A Qualitative Analysis in Three Countries.
67th Congress of FIP (2007), Beijing, China
45. Benrimoj, S.I., Oller Dolcet, H, Martinez, F., Fernandez-Limos, F. Community Pharmacists
Awareness on Quality Management. 67th Congress of FIP (2007), Beijing, China
46. Benrimoj, S.I., Roberts, Feletto, E., A. Organizational Flexibility In Community Pharmacy. 67th
Congress of FIP (2007), Beijing, China.
47. Benrimoj, S.I., Oller Dolcet, H, Martinez, F., Fernandez-Limos, F. Patient Simulation Method:
Nomenclature and Use. 67th Congress of FIP (2007), Beijing, China.
48. Benrimoj, S.I., Roberts, A. A Holistic Approach Change Management for Community Pharmacy.
67th Congress of FIP (2007), Beijing, China.
49. Benrimoj, S.I., Oller Dolcet, H, Martinez, F., Fernandez-Limos, F. Quality in Cognitive Services
Provision Community Pharmacy. 67th Congress of FIP (2007), Beijing, China.
50. Benrimoj, S.I., Paulino, E., Costa, F. Community Pharmacy Practice Change: an investigation on
the willingness of doctors to collaborate. PCNE (2007), Gothenburg, Sweden.
51. Feletto, E., Oller Dolcet, H., Fernandez-Llimos, F., Roberts, A., Benrimoj, S.I. An International
approach to linking quality systems and business capabilities to enhance viability and the
implementation of patient orientated services in community pharmacy. PCNE (2007), Gothenburg,
Sweden.
52. Feletto, E., Dunphy, D.C., Palmer, I.C., Benrimoj, S.I., Roberts, A.S. Practice Change in
Community Pharmacy-Tools for Service Implementation. PCNE (2007), Gothenburg, Sweden.
53. Feletto, E., Roberts, A.S., Benrimoj, S.I. Optimizing business viability in Australian community
pharmacies by integrating cognitive pharmacy services. PCNE (2007), Gothenburg, Sweden.
54. Feletto, E., Dunphy, D.C., Palmer, I.C., Frommer, M., Benrimoj, S.I., Roberts, A.S. An industry
approach to practice change in community pharmacy. PCNE (2007), Gothenburg, Sweden.
55. Oller Dolcet, H., Benrimoj, S.I., Fernandez-Llimos, F. A theoretical framework for the
implementation of patient-oriented pharmacy services using a quality management system. PCNE
(2007), Gothenburg, Sweden.
29
56. Benrimoj, S.I., Raffaele, C., Werner J.B. Improving the quality of service delivered by Australian
community pharmacists in the management of non-prescription medicines: a pseudo-patron study.
I J P P (2006), International Social Pharmacy Workshop, Oxford, United Kingdom, Volume 14:
Supplement 1:A59.
57. Benrimoj, S.I., Werner J.B., Raffaele, C., De Almeida Neto, A.C. Pseudo-patron research
methodology: data errors and the need for validation. I J P P (2006), International Social Pharmacy
Workshop, Oxford, United Kingdom, Volume 14: Supplement 1:A58.
58. Roberts, A.S., Benrimoj, C., Chen, T.F., Williams, K.A., Aslani, P. Innovation in Australian
community pharmacies: Characteristics of adopters. Joint Meeting of ASCEPT and APSA,
December 2005, Melbourne.
59. Gastelurrutia, M.A., Faus, M.J., Benrimoj, S.I., Baena, M.I., Fajardo, P., Fernandez-Llimos, F.
Facilitators for Disseminating and Implementing Cognitive Services in Spanish Community
Pharmacies: A Qualitative Study. The 5th ESCP Spring Conference on Clinical Pharmacy, May
2005, Stockholm, Sweden.
60. Gastelurrutia, M.A., Faus, M.J., Benrimoj, S.I., Baena, M.I., Fajardo, P., Fernandez-Llimos, F.
Barriers for Disseminating and Implementing Cognitive Services in Spanish Community
Pharmacies: A Qualitative Study. The 5th ESCP Spring Conference on Clinical Pharmacy, May
2005, Stockholm, Sweden.
61. Benrimoj, S.I. Pharmaceutical International Network (PIN): a model for international research
and policy collaboration. Pharmaceutical Care Network Europe Fourth International Workshop
Conference, February 2005, Hillerød, Denmark.
62. Moles, R, Brien, J, Benrimoj, S.I. Providing professional pharmacy services to private hospital
patients. Pharmaceutical Care Network Europe Fourth International Workshop Conference,
February 2005, Hillerød, Denmark.
63. Roberts, A.S., Benrimoj, S.I., Chen, T.F., Williams, K.A., Aslani, P. Implementing change in
community pharmacy: facilitating factors. Pharmaceutical Care Network Europe Fourth
International Workshop Conference, February 2005, Hillerø, Denmark.
64. Wilson, F.L., Benrimoj, S.I. Benchmarking Australian Pharmacy Performance with Non-
Prescription Medications. Pharmaceutical Care Network Europe Fourth International Workshop
Conference, February 2005, Hillerød, Denmark.
65. Paulio, E., Costa, F., Benrimoj, S.I. Dissemination of Practice Change in Community Pharmacy
Practice: Are doctors willing to play? Pharmaceutical Care Network Europe Fourth International
Workshop Conference, February 2005, Hillerød, Denmark.
66. Moles, R, Brien, J, Benrimoj, S.I.. Providing professional pharmacy services to private hospital
patients. Pharmaceutical Care Network Europe Fourth International Workshop Conference,
February 2005, Hillerød, Denmark.
67. Pharmaceutical Care Network Europe Fourth International Workshop Conference, February 2005,
Hillerød, Denmark. Pharmaceutical Care Research - Beyond the Pharmacy Perspective.
68. A.P.S.A., Melbourne, 2004. Facilitators of Practice Change in Community Pharmacy (co-author).
69. A.P.S.A., Melbourne, 2004. Testing the International Transportability of a Model of Practice
Change (co-author).
70. A.P.S.A., Melbourne, 2004. Measuring Outcomes of Professional Pharmacy Services to Private
Hospital Patients (co-author).
71. Emmerton, L., Bayari, C., Taylor, R., Raffaele, C., Werner, J., Williams, K., Benrimoj, S.I. A
method for measurement and analysis of interventions associated with Pharmacist Only and
Pharmacy Medicines in Australia. Proceedings of the National Medicines Symposium, Brisbane,
2004.
72. Gadiel, D., Doessel, D., and Benrimoj, S.I. Welfare economics of retail pharmacy, 25th Australian
Conference of Health Economists, Canberra, 2003.
73. Emmerton, L., Benrimoj, S.I.., Williams, K., Taylor, R., Gadiel, D., Taylor, S., Carroll, P., Gilbert,
A., Wolk, J., and Raffaele, C. A conceptual approach for measurement of clinical benefits
associated with Pharmacist Only and Pharmacy Medicines in Australia: work in progress.
Proceeding of the 63rd
FIP Pharmacy World congress and 9th Pharmacy Australia Congress,
Sydney, 2003.
30
74. A.P.S.A., Sydney, 2003. Assessment of patient counselling practices in Finnish community
pharmacies using pseudo-patron method (co-author).
75. A.P.S.A., Sydney, 2003. Community pharmacists in general medical practices – the costs and
benefits (co-author).
76. A.P.S.A., Sydney, 2003. A conceptual approach for measurement of clinical benefits associated
with pharmacist only and pharmacy medicines in Australia: work in progress (co-author).
77. A.P.S.A., Sydney, 2003. M.E.S. – A new private hospital pharmacy service (co-author).
78. A.P.S.A., Sydney, 2003. Development of a practice change model for community pharmacy (co-
author).
79. Emmerton, L., Benrimoj, S.I., Williams, K., Taylor, R., Gadiel, D., Taylor, S., Carroll, P., Gilbert,
A., Wolk, J., Raffaele, C., Bayari, C. A conceptual approach for measurement of clinical benefits
associated with Pharmacist Only and Pharmacy Medicines in Australia: work in progress.
Queensland Health and Medical Scientific Meeting, Brisbane, 2003.
80. Roberts, A.S., Hopp, T., Sørensen, E.W., Benrimoj, S.I., Chen, T., Herborg, H., Williams, K.,
and Aslani, P. Cognitive pharmaceutical services: A novel qualitative research instrument to
investigate practice change in community pharmacy [Conference abstract]. J S A P (2002) 19
(6):226
81. Moles, R., Brien, J., and Benrimoj, S.I. Implementing professional pharmacy services in NSW
private hospitals – work in progress [Conference abstract]. J S A P (2002),19 (6) 249-250.
82. A.P.S.A., Melbourne, 2002. Community pharmacists providing cognitive pharmacy services from
the GP practice – the effect on pharmaceutical and medical services (co-author).
83. A.P.S.A., Melbourne, 2002. A qualitative investigation of practice change in community
pharmacy (co-author).
84. A.P.S.A., Melbourne, 2002. Evaluation of the efficacy of throat lozenges using digital
photography (co-author).
85. A.P.S.A., Melbourne, 2002. A qualitative study of pharmacist’s views on the implementation of
medication education services and medication review services in NSW private hospitals (co-
author).
86. Pharmaceutical Care Network Europe Working Conference, Hilleroed, February 2003.
Understanding practice change in community pharmacy: A qualitative study in Australia (co-
author).
87. Australasian Pharmaceutical Science Association Scientific Meeting, Melbourne, December 2002.
A qualitative investigation of practice change in community pharmacy (co-author).
88. The University of Sydney College of Health Sciences’ 3rd Research Conference, Leura,
September 2002. Development of a qualitative research instrument to investigate practice change
in community pharmacy (co-author).
89. Pharmacy World Congress FIP, France, 2002. Development of a research instrument to describe
and understand the factors affecting practice change in community pharmacy (co-author).
90. Pharmacy World Congress FIP, France, 2002. Pharmacy models and services in New South
Wales private hospitals (co-author)
91. Pharmacy Australia Congress, Hobart, 2002. Quality care pharmacy support centre (co-author).
92. 12th International Social Pharmacy Workshop, Sydney, 2002. Community pharmacists providing
professional pharmacy services to patients in general medical practices – an Australian model of
interprofessional collaboration (co-author).
93. 12th International Social Pharmacy Workshop, Sydney, 2002. Implementation and dissemination
of cognitive pharmaceutical services: A novel approach to developing a qualitative research
instrument to investigate practice change in community pharmacy (co-author).
94. 12th International Social Pharmacy Workshop, Sydney, 2002. Implementing professional
pharmacy services in NSW private hospitals (co-author).
95. Pharmacy Board of the Australian Capital Territory, Canberra, 2002. Results of the S2/S3 project.
96. A.P.S.A., Melbourne, 2001. A model that links national quality use of medicines (QUM) policy to
practical implementation at the local level (co-author).
97. A.P.S.A., Melbourne, 2001. Census of pharmacy models and services in New South Wales private
hospitals (co-author).
31
98. A.P.S.A., Melbourne, 2001. Evaluation of a novel objective method to assess the efficacy of throat
lozenges (co-author).
99. A.P.S.A., Melbourne, 2001. Transporting a non-prescription medicine model of practice from
Australia to the United Kingdom (co-author).
100. A.P.S.A., Melbourne, 2001. Evaluating the effect of general practice pharmacists providing
professional pharmacy services from general medical practices using Health Insurance
Commission (HIC) data (co-author).
101. Pharmacy World Congress FIP, Singapore, 2001. International collaboration and non-prescription
medication services (co-author).
102. Pharmacy World Congress FIP, Vienna, 2000. The pharmaceutical industry as a useful resource
for pharmacy education (co-author).
103. Pharmacy World Congress FIP, Vienna, 2000. Standards for the provision of pharmacist only and
pharmacy medicines in community pharmacies in Australia (co-author).
104. Pharmacy World Congress FIP, Vienna, 2000. Telepharmacy : videoconferencing as a method of
providing pharmaceutical services (co-author).
105. A.P.S.A., Newcastle, 2000. Diabetes care in community pharmacy – training the pharmacists (co-
author).
106. A.P.S.A., Newcastle, 2000. General practice pharmacists - providing professional pharmacy
services from general medical practices – work in progress (co-author).
107. A.P.S.A., Newcastle, 2000. Interviews with NSW private hospital pharmacists – current models of
service provision (co-author).
108. A.P.S.A., Newcastle, 2000. A novel way to differentiate between effective and ineffective throat
lozenges (co-author).
109. A.P.S.A., Newcastle, 2000. Implementation of the standards for the provision of pharmacist only
and pharmacy medicines (co-author).
110. Pharmacy Australia Congress, Sydney, 2000. Service model for type 2 diabetes in community
pharmacy (co-author).
111. Pharmacy Australia Congress, Sydney, 2000. General practice pharmacists – the delivery of
pharmaceutical services in a general medical practice (co-author).
112. A.P.S.A., Fremantle, 1999. A conceptual model for best pharmacy practice in non-prescription
medicine (co-author).
113. A.P.S.A., Fremantle, 1999. Intervention strategies and training programs for pharmacy (co-author).
114. A.P.S.A., Fremantle, 1999. Interviews with pharmacists providing services to private hospitals (co-
author).
115. A.P.S.A., Fremantle, 1999. Development of an innovative method to assess the efficacy of throat
lozenges (co-author).
116. A.P.S.A., Fremantle, 1999. Consumer medicine information- trends in use (co-author).
117. A.P.S.A., Fremantle, 1999. Patient medication management services in coordinated care trials (co-
author).
118. A.P.S.A., Fremantle, 1999. Community pharmacists providing professional pharmacy services
from a general medical practice- work in progress (co-author).
119. Pharmacy World Congress FIP, Spain, 1999. Changing Swiss pharmacists and pharmacy
assistants’ practice in dealing with direct requests for non-prescription analgesics (co-author).
120. Pharmacy World Congress FIP, Spain, 1999. Qualitative interviews with Australian private
hospital pharmacists (co-author).
121. Pharmacy World Congress FIP, Spain, 1999. Development of a novel method to assess the
efficacy of throat lozenges (co-author).
122. Pharmacy World Congress FIP, Spain, 1999. Intervention strategies and training programs for
pharmacy settings (co-author).
123. Pharmacy World Congress FIP, Spain, 1999. Telepharmacy in rural Australia – a pilot study on
the delivery of drug information services via videoconferencing (co-author).
124. Pharmacy World Congress FIP, Spain, 1999. Pharmacist remuneration for preventive primary
healthcare. An international perspective (co-author).
125. Pharmacy World Congress FIP, Holland, 1998. Strategy for monitoring non-prescription drugs
under actual conditions of use (co-author).
32
126. Pharmacy World Congress FIP, Holland, 1998. Developing a rural model of pharmacy practice
(co-author).
127. Pharmacy World Congress FIP, Holland, 1998. University of Sydney and Warner Lambert
consumer health care initiative for treating and counselling heartburn and indigestion sufferers
(SWITCH) (co-author).
128. Pharmacy World Congress FIP, Holland, 1998. Pharmacy-based protocols: A training mechanism
(co-author).
129. Pharmacy World Congress FIP, Holland, 1998. Pharmaceutical services to Australian private
hospitals (co-author).
130. Pharmacy World Congress FIP, Holland, 1998. Community pharmacists’ attitude to the use of
consumer medicine information (co-author).
131. Pharmacy World Congress FIP, Holland, 1998. Evaluating the impact of a protocol training
program on pharmacy assistant non-prescription medication supply (co-author).
132. Pharmacy World Congress FIP, Holland, 1998. The development of National standards of practice
for handling of over the counter medicines (co-author).
133. Pharmacy World Congress FIP, Holland, 1998. Collaboration between community pharmacists
and general medical practitioners in the medication process (co-author).
134. Pharmacy World Congress FIP, Holland, 1998. The use of consumer medicines information in
verbal medication counselling: predictors of behaviour (co author).
135. Pharmacy World Congress FIP, Holland, 1998. A medication management service in coordinated
care setting (co-author).
136. 11th Social Pharmacy Conference Belgium, 1998. O’Brien J.A., Patel, N., Bowden, M., Langford,
J.H., Benrimoj, S.I. University of Sydney and Warner Lambert Consumer Healthcare (WLCHC)
Initiative for Treating and Counselling Heartburn and Indigestion Sufferers (SWITCH) J Soc
Admin Pharm (1999) 16(2): 100.
137. 11th Social Pharmacy Conference, Belgium, 1998. Kelly F.S., and Benrimoj, S.I. Evaluation of the
Impact of a Protocol Training Program on Pharmacy Assistant Non-Prescription Medication
Supply to Consumers J Soc Admin Pharm (1999) 16(2):85-86.
138. 11th Social Pharmacy Conference, Belgium, 1998. Crampton, M., Quintrell, N., Gilbert, A.,
Benrimoj, S.I. The Development of National Standards for the Provision of Over-the-Counter
Medicines J Soc Admin Pharm (1999) 16(2):78-79.
139. 11th Social Pharmacy Conference, Belgium, 1998. Aslani, P., Krass, I., Benrimoj, S.I. The
Development and Implementation of Two Interventions for the Use of Consumer Medicine
Information by Community Pharmacists J Soc Admin Pharm (1999) 16(2):74-75.
140. 11th Social Pharmacy Conference, Belgium, 1998. Program-based intervention strategies : a
training program (co-author).
141. 11th Social Pharmacy Conference, Belgium, 1998. Inappropriate use of non-prescription NSAIDs
(co-author).
142. 11th Social Pharmacy Conference, Belgium, 1998. The development and implementation of two
interventions for the use of consumer medicine information by community pharmacists (co-
author).
143. 11th Social Pharmacy Conference, Belgium, 1998. Impact of a training programme and medication
review meetings on communication between community pharmacists and GPs (co-author).
144. 11th Social Pharmacy Conference, Belgium, 1998. An evaluation of two interventions for the use
of consumer medicine information by community pharmacists (co-author).
145. 11th Social Pharmacy Conference, Belgium, 1998. Developing a rural model of pharmacy practice
(co-author).
146. 11th Social Pharmacy Conference, Belgium, 1998. The provision of a medication management
service to community patients in a coordinated care setting (co-author).
147. 11th Social Pharmacy Conference, Belgium, 1998. The development of national standards for the
provision of over the counter medicines (co-author).
148. A.P.S.A., Hobart, 1998. Standards for the quality use of pharmacy and pharmacist only medicines
in Australian community pharmacy (co-author).
149. A.P.S.A., Hobart, 1998. Application of HPLC to study inflammatory mediators in pharyngitis (co-
author).
33
150. A.P.S.A., Hobart, 1998. Impact of a multi-staged intervention model on telephone communication
between community pharmacists and general medical practitioners (co-author).
151. A.P.S.A., Hobart, 1998. Impact of protocols and training on pharmacy assistants response to
consumer requests for non-prescription medicines or health related advice (co-author).
152. A.P.S.A., Hobart, 1998. The impact of training on the use of consumer medicine information by
community pharmacists (co-author).
153. A.P.S.A., Hobart, 1998. Models of pharmaceutical services in Australian private hospitals :
preliminary study (co-author).
154. A.P.S.A., Hobart, 1998. An evaluation of a medication management service to community patients
in a coordinated care setting- work in progress (co author).
155. A.P.S.A., Hobart, 1998. Pharmacy based interventions strategies: A training program (co-author).
156. A.P.S.A., Hobart, 1998. University of Sydney and Warner Lambert Healthcare initiative for
treating and counselling Heartburn and indigestion sufferers (co-author).
157. A.P.S.A., Sydney, 1997. Development of interventions for the use of CMI by community
pharmacists (co-author).
158. A.P.S.A., Sydney, 1997. The development of guidelines for the delivery of a patient medication
service in a coordinated care setting (co-author).
159. A.P.S.A., Sydney, 1997. Multinomial logit (MNL) for pharmacists’ recommendation of the active
ingredient(s) of nonprescription analgesics for a migraine headache (co-author).
160. A.P.S.A., Sydney, 1997. Pharmacy-based intervention strategies: a training program (co-author).
161. A.P.S.A., Sydney, 1997. Preliminary analysis of the provision of a nonprescription medication
service by pharmacy assistants (co-author).
162. A.P.S.A., Sydney, 1997. Pharmacists Management of OTC H2 antagonists (co-author).
163. A.P.S.A., Sydney, 1997. A randomised trial on the effect of education and a professional
allowance on clinical intervention rates in pharmacy: Clinical impact (co-author).
164. A.P.S.A., Sydney, 1997. Communication and collaboration between community pharmacists and
general practitioners in the medication regimen review process (co-author).
165. A.P.S.A., Sydney, 1997. Development of a model to facilitate collaboration between community
pharmacists and general practitioners in the medication regimen review process (co-author).
166. A.P.S.A., Sydney, 1997. A practical system which categorises patients into four risk groups
highlighting those who would most benefit from a medication review (co-author).
167. A.P.S.A., Melbourne, 1996. Pilot survey of community pharmacist self-reported behaviour and
attitudes to medication regimen reviews: A preliminary analysis (co-author).
168. A.P.S.A., Melbourne, 1996. Pharmacy-based research: Methodology (co-author).
169. A.P.S.A., Melbourne, 1996. Pilot survey of inter-professional contacts between community
pharmacists and general medical practitioners (co-author).
170. A.P.S.A., Melbourne, 1996. A test of nested vs non-nested structure by use of discrete choice
modelling in determining pharmacists’ recommendation of non-prescription analgesics for a
tension headache (co-author).
171. A.P.S.A., Melbourne, 1996. Pharmacy recruitment for a pharmacoepidemiological survey of
nonprescription NSAID products (co-author).
172. A.P.S.A., Melbourne, 1996. An evaluation of the relationship between NSW community
pharmacists’ attitudes to Consumer Product Information (CPI) and practice behaviour (co-author).
173. A.P.S.A., Melbourne, 1996. A survey of NSW community pharmacists self-reported behaviours
in the use of Consumer Product Information (CPI) (co-author).
174. Pharmacy Australia Congress, Melbourne, 1996. Community pharmacists and general
practitioners: how often and why do they communicate? (co-author)
175. Pharmacy Australia Congress, Melbourne, 1996. Financial benefits to community pharmacy
arising from the delivery of patient drug information (co-author).
176. Pharmacy Australia Congress, Melbourne, 1996. Pharmacy-based experimental research:
Methodology (co-author).
177. Pharmacy Australia Congress, Melbourne, 1996. Pharmacists’ brand recommendation of non-
prescription analgesics for a simple headache (co-author).
178. Pharmacy Australia Congress, Melbourne, 1996. Pilot survey of community pharmacists attitudes
and self reported behaviours in the use of consumer product information (CPI) (co-author).
34
179. Pharmacy Australia Congress, Melbourne, 1996. Inappropriate use of non-prescription (S2)
NSAID medication (co-author).
180. A.P.S.A., Adelaide, 1995. A comparative clinical trial of topical agents in the prevention of
wound infection (co-author).
181. A.P.S.A., Adelaide, 1995. Risk factors associated with the inappropriate use of non-prescription
non-steroidal anti-inflammatory drugs in primary dysmenorrhoea: preliminary results (co-author).
182. A.P.S.A., Adelaide, 1995. Attitudes of general practitioners to community pharmacists
involvement in the medication regimen review process: a qualitative study (co-author).
183. A.P.S.A., Adelaide, 1995. Analysis of telephone interaction between community pharmacists and
general medical practitioners (co-author).
184. A.P.S.A., Adelaide, 1995. Use of discrete choice modelling in determining pharmacists’ brand
recommendation of non-prescription analgesics (co-author).
185. A.P.S.A., Adelaide, 1995. A qualitative study of community pharmacists’ attitudes and behaviours
in the use of consumer product information (co-author).
186. Federal Conference of the Society of Hospital Pharmacists of Australia Discharge Systems and
Their Impact on the Detection of Discharge Prescription Errors at Three Sydney Teaching
Hospitals. Aust J Hosp Pharm (1995) 25 (1) (co-author).
187. Pharmacy Australia Congress, Sydney, 1995. The Impact of Workflow Changes on Prescription
Numbers in Community Pharmacies (co-author).
188. Pharmacy Australia Congress, Sydney, 1995. Pilot Survey of Community Pharmacists
Recommendation of Non-prescription Analgesics for a Simple/Tension/Migraine Headache (co-
author).
189. Pharmacy Australia Congress, Sydney, 1995. Changes in Therapy as a Result of Community
Pharmacists' Proactive Clinical Interventions with the Pharmaceutical Benefits Scheme (co-
author).
190. Pharmacy Australia Congress, Sydney, 1995. Identification of Barriers to Community Pharmacists
Conducting Medication Regimen Reviews: Preliminary Results of a Qualitative Study (co-author).
191. Pharmacy Australia Congress, Sydney, 1995. Review of Computerised Patient Medication
Records to Determine Potential Clinical Interventions in Community Pharmacy (co-author).
192. Pharmacy Australia Congress, Sydney, 1995. Developing Therapeutic Drug Concentrations for a
Nonprescription Topical Antimicrobial Preparation. (co-author).
193. Pharmacy Australia Congress, Sydney, 1995. Consumer Use of Nonprescription Primary
Dysmenorrhoea Products (co-author).
194. A.P.S.A., Auckland, New Zealand, 1994. The Financial Impact of Professional Services on
Community Pharmacies (co-author).
195. A.P.S.A., Auckland, New Zealand, 1994. Effect of Prostaglandin E2 Gel on High-Cost Clinical
Outcomes (co-author).
196. A.P.S.A., Auckland, New Zealand, 1994. Development of a Therapeutically Appropriate
Nonprescription Topical Antimicrobial Preparation (co-author).
197. A.P.S.A., Auckland, New Zealand, 1994. Pharmaco-epidemiological Survey of Nonprescription
Primary Dysmenorrhoea Products: A Pilot Study (co-author).
198. A.P.S.A., Auckland, New Zealand, 1994. Pharmacists' Clinical Interventions associated with the
Pharmaceutical Benefits Scheme - Pilot Study (co-author).
199. A.P.S.A., Auckland, New Zealand, 1994. Medication Regimen Reviews: A Collaborative Project
between Community Pharmacists and General Practitioners. Identification of Barriers to
Community Pharmacists: Preliminary Results of a Qualitative Study (co-author).
200. Pharmacy Australia Congress, Sydney, 1994. Potential for revision of a topical antimicrobial
preparation (co-author).
201. Pharmacy Australia Congress, Sydney, 1994. Development of Continuing Education Material for
Community Pharmacists (co-author).
202. Pharmacy Australia Congress, Sydney, 1994. A Conceptual and Feasible Approach to Workflow
Changes in Community Pharmacy (co-author).
203. Pharmacy Australia Congress, Sydney, 1994. Pharmaco-epidemiological Survey of Non-
prescription Primary Dysmenorrhoea Products (co-author).
35
204. Pharmacy Australia Congress, Sydney, 1994. Pharmacists' Clinical and Administrative
Interventions Associated with the Pharmaceutical Benefits Scheme - Preliminary Results (co-
author).
205. Pharmacy Australia Congress, Sydney, 1994. Consumer Use of Non-prescription Analgesic
Products - NSW and Queensland Qualitative Results (co-author).
206. Federal Conference of the Society of Hospital Pharmacists of Australia, Sydney 1993.
Documentation of Pharmacists' Clinical Intervention - a Multicentre Study in Four Teaching
Hospitals (co-author).
207. Federal Conference of the Society of Hospital Pharmacists of Australia, Sydney 1993. Definition
of a Pharmacist's Clinical Intervention - Poster (co-author).
208. A.P.S.A., Brisbane, 1993. The Financial Impact of Providing Professional Services on
Community Pharmacies - Preliminary results (co-author).
209. A.P.S.A., Brisbane, 1993. Pharmacists' Attitudes to Restrictions Associated with the Supply of
Schedule 3 Medicines (co-author).
210. A.P.S.A., Brisbane, 1993. Factors Affecting Pharmacists' Choice of Non-Prescription Analgesics
(co-author).
211. A.P.S.A., Brisbane, 1993. Clinical Rationale for Non-Prescription Topical Antimicrobial
Preparations (co-author).
212. A.P.S.A., Brisbane, 1993. A Pilot Study Comparing Two Methodologies for Post-rescheduling
Surveillance of Non-Prescription Primary Dysmenorrhoea Products (co-author).
213. State Branch Conferences, 1992. Discharge medication and continuity of treatment. Aust J Hosp
Pharm 23(1):49 (co-author).
214. A.P.S.A., Dunedin, New Zealand, 1992. Influences on pharmacists' recommendation of cough and
cold products (co-author).
215. A.P.S.A., Dunedin, New Zealand, 1992. Pharmacists' attitudes towards the switch of medicines
from prescription to non-prescription (co-author).
216. A.P.S.A., Adelaide, 1991. The rationality of antihistamines in cough and cold products (co-
author).
217. A.P.S.A., Adelaide, 1991. The switch of medicines from prescription to non-prescription:
preliminary results (co-author).
218. A.P.S.A., Adelaide, 1991. Use of non-prescription medicines by people with diabetes (co-author).
219. A.P.S.A., Adelaide, 1991. In vitro interactions of neomycin sulphate, bacitracin, and polymyxin B
sulphate (co-author).
220. A.P.S.A., Adelaide, 1991. Pharmacists' recommendation of cough and cold products: preliminary
results (co-author).
221. A.P.S.A., Adelaide, 1991. The structure of the community practice experience.
222. A.P.S.A., Melbourne, 1989. Reconceptualization of pharmacy practice education.
223. A.P.S.A., Melbourne, 1989. Classification of pharmacies providing diabetic services (co-author).
224. A.P.S.A., Melbourne, 1989. Epidemiological study on non-prescription medications and
hypertensive patients (co-author).
225. A.P.S.A., Melbourne, 1989. Influences on pharmacists' recommendation of non-prescription
medications (co-author).
226. A.P.S.A., Melbourne, 1989. Health behaviour of non-prescription medication purchasers
(co-author).
227. Federal Conference of the Society of Hospital Pharmacists of Australia, Hobart, 1987. Computers
in pharmacy education in Queensland (co-author).
228. British Pharmaceutical Conference, Jersey, 1986. Diabetic services from community pharmacy
(co-author).
229. 4th Social Pharmacy Workshop, Methodologies in Pharmaceutical Research. Sweden, 1986. Use
of the video for practice analysis (co-author).
230. A.P.S.A., Brisbane, 1985. Pharmaceutical Benefits dispensing - views on remuneration (co-
author).
231. A.P.S.A., Brisbane, 1985. The video as a method of work sampling (co-author).
232. A.P.S.A., Brisbane, 1985. Specialised services from community pharmacy in Queensland
(co-author).
36
233. American Pharmacists' Association, Annual Conference, U.S.A., 1985. Non-prescription drugs in
community pharmacy, socio-economic and usage patterns (co-author).
234. American Pharmacists' Association, Annual Conference, Scientific Section, San Antonio, U.S.A.,
1985. Non-prescription drugs in community pharmacy, purchaser and staff behaviour (co-author).
235. Craig, M., Benrimoj, S.I., Low, J., Cargill, K. Work patterns pre- and post- computerisation. Aust
J Hosp Pharm (1985) 256:54.
236. Moshovelis, J., Craig, M., Benrimoj, S.I., Low, J., Just, D. Dispensing times pre- and post-
computerisation. Aust J Hosp Pharm (1985) 256:54.
237. A.P.S.A., Melbourne, 1983. A conceptual scheme approach to a data base for drug information in
community pharmacy (co-author).
238. A.P.S.A., Melbourne, 1983. O.T.C. medication sales in community pharmacy, 2. Consumer
aspects (co-author).
239. A.P.S.A., Melbourne, 1983. O.T.C. medication sales in community pharmacy, 1. Direct product
requests and symptom presentation (co-author).
240. Federal Conference of the Society of Hospital Pharmacists of Australia, Adelaide, 1983. Hospital
discharge medication: an analysis (co-author).
241. Federal Conference of the Society of Hospital Pharmacists of Australia, Adelaide, 1983.
Monitoring of long-term drug therapy of mentally retarded patients in selected models of care
(co-author).
242. A.P.S.A., Sydney, 1982. Education of the I.P.A.L.S. audio-visual pathology course used by final
year Pharmacy students (co-author).
243. A.P.S.A., Sydney, 1982. An analysis of the system controlling approval to supply Pharmaceutical
Benefits under the National Health Act in Queensland (co-author).
37
14. INVITED PRESENTATIONS – PROFESSIONAL CONFERENCES
14.1 International 1. 74th International Congress of FIP, 2014. Bangkok, Thailand. Pharmacy Practice Research:
Access to Medicines and Pharmacists’ Influence on Medication Adherence.
2. 74th International Congress of FIP, 2014. Bangkok, Thailand. Forum For Innovators:
Pharmaceutical Services Implementation - Success and Outcomes.
3. 1st International Conference on Professional Services (Video Conference), 2014. Cordoba,
Argentina. Pharmaceutical Professional Services: A new model of exercising pharmacists to
strengthen and monetize their professional practice, developing services for patients and the
community at large.
4. Universidad De Costa Rica Colegio De Farmacéuticos De Costa Rica, 2014. Corobici, Costa
Rica. Programa Consigue: El Impacto Clinico, Economico y Humanistico del Seguimiento
Farmacoterapeutico.
5. 5th World Healthcare Students Symposium, 2013, Lausanne, Switzerland. Innovation: Which
Strategy to Implement a New Service.
6. Conceptual Framework of the Evolution of the Health System: How to Overcome the Obstacles of
Change. 5th World Healthcare Students Symposium, 2013, Lausanne, Switzerland.
7. Remuneration and implementation of cognitive pharmaceutical services for complex patients in
community pharmacy. FIP World Congress of Pharmacy and Pharmaceutical Sciences 2013,
Dublin, Ireland.
8. Australian Models of Community Pharmacy and Cognitive Services Secondary to Medications.
XXI Congreso de la Federacion Farmaceutica Sudamericana 2012, Argentina.
9. Emerging community pharmacy business models – professional and financial implications. 71th
International congress FIP 2011, Forum for Innovators, Hyderabad, India
10. Educating Pharmacists to Provide New Pharmacy Services. XVII European Association of
Faculties of Pharmacy Annual Congress, 2011 Lisbon, Portugal.
11. Professional Pharmacy Services: Emerging practice and Business Models. Ordre des Pharmaciens
du Quebec, 2011 Montreal, Canada.
12. Medication Management Services In Australia. Danish Pharmacist Society 2011 Vejle, Denmark.
13. [Pharmacy and pharmaceutical services] 17th National Pharmacy Congress 2010 Bilbao, Spain.
14. Emerging community pharmacy business models – International trends. 70th International congress
FIP 2010, Lisbon, Portugal
15. Emerging community pharmacy business models – professional and financial implications. 70th
International congress FIP 2010, Forum for Innovators, Lisbon, Portugal
16. [Programa conSIGUE] FORO 2010, Madrid, Spain.
17. PSA Refresher Course, Shangai, China, 2010. 5th CPA services.
18. PSA Refresher Course, Shangai, China, 2010. Health solution orientated services – internal
organization.
19. PSA Refresher Course, Beijing, China, 2010. Health solution orientated services – capacity
building.
20. PSA Refresher Course, China, Beijing, 2010. Health solution orientated services – strategic
choices.
21. PSA Refresher Course, China, Beijing, 2010. Practical approach to implementing viable CPA
professional services.
22. [Evaluation of Medication Management review with Follow up (SFT)], Simpodader (2009),
Gerona, Spain. Arspharmaceutica 2010, 51, 11-27. ISSN: 0004-2927.
23. Change Management in the Context of Pharmacy Practice, Symposium swissYPG 2009, Bern,
Switzerland
24. Quality Systems in Community Pharmacy.69th Congress of FIP 2009, Istanbul, Turkey
25. “Atención Farmacéutica”. Congreso FeFas 2009, Argentina (by videoconference)
26. Benrimoj, S. I. Pharmacy Practice Research. An Australian Perspective. Pharmacy Practice
Research Trust 2008, London, United Kingdom
38
27. Benrimoj, S.I. From Capacity Building to Implementation: The Role of Universities, National
Professional Organisations and International Organisations. 68th Congress of FIP 2008, Basel,
Switzerland.
28. Benrimoj, S.I., Roberts, A. Change Management in Community Pharmacy: An Introduction to
Management Concepts as They Relate to Community Pharmacy. 68th Congress of FIP 2008,
Basel Switzerland.
29. Benrimoj, S.I. Change Management – The Process of Facilitating Change. 68th Congress of FIP
2008, Basel, Switzerland.
30. PSA Refresher Course, South America, 2008. Are We Improving Our Professional Practice
Performance In Dealing With Non-Prescription Medication?
31. PSA Refresher Course, South America, 2008. Payment and Practice of Diabetes and Asthma
Disease State Management in Australia.
32. PSA Refresher Course, South America, 2008. How to Implement Professional Services in Your
Pharmacy – a practical approach.
33. Benrimoj, S.I. Implementation and Integration of Medication Reviews into Health Care. 67th
Congress of FIP 2007, Beijing, China.
34. Benrimoj, S.I., Roberts, A. How to Implement Best Practice Standards: Prerequisites,
Facilitators, Tools, Incentives and Sanctions. An Example Using Non-Prescription Medicines in
Australia. 67th Congress of FIP 2007, Beijing, China.
35. Benrimoj, S.I., Roberts, A. Dissemination, Quality Control and Documentation: Standards for
Non-Prescription Medicines in Australia. 67th Congress of FIP 2007, Beijing, China.
36. Benrimoj, S.I., Roberts, A. Setting Standards for Best Practice: Non-Prescription Medicines in
Australia. 67th Congress of FIP 2007, Beijing, China.
37. PSA Refresher Course, Spain, 2007. Disease State Management and its practical implementation.
38. PSA Refresher Course, Spain, 2007. Potential roles for pharmacists in the future: pharmacists
prescribing, immunization… will you be ready?
39. PSA Refresher Course, Spain, 2007. How to handle S3 inquiries.
40. PSA Refresher Course, Spain, 2007. New developments in pharmacy: what’s the rest of the world
doing?
41. National Congress of Pharmacists, Lisbon, Portugal, 2007. The Role of pharmaceutical Societies,
professional organizations and universities in the excellence of pharmaceutical practice.
42. European Conference on Community Pharmacy, Barcelona, Spain 2007. Implementation of
cognitive services in the community pharmacies.
43. GRIPP Symposium, Geneva, Switzerland, 2007. International Pharmacy Practice Research.
44. PSA Refresher Course, Japan, 2006. How Pharmacy will manage its Future Change.
45. ABDA – Federal Union of German Associations of Pharmacists, Symposium, Berlin, 2006.
Medicines Management for the Elderly with Polypharmacy – (Home) Medication Review for
Improved Patient Safety.
46. University of Lisbon, Lisbon, Portugal, 2006. Evaluation of intervention in community pharmacy.
47. OF, Lisbon, Portugal, 2006. Cost - benefit analysis of intervention by community pharmacy in
Australia.
48. PSA Refresher Course, Dubai, 2005. The Future of Health Care in Australia.
49. PSA Refresher Course, Dubai, 2005. Opportunities for Community Pharmacy in Australia.
50. PSA Refresher Course, Munich, 2005. A Professional Front of Shop Strategy.
51. PSA Refresher Course, Prague, 2005. Actual Effective S2 S3 interventions.
52. PSA Refresher Course, Danube, 2005. Change Management in Community Pharmacy.
53. C.E.F.A.R., Lisbon, 2004. Recent changes in Australian pharmacy system.
54. Australian Pharmaceutical Industries (API), South Africa, 2004. Disease Statement Management.
55. PSA Refresher Course, Canada, 2004. Pharmacy interventions: OTC medicines.
56. PSA Refresher Course, Canada, 2004. Pharmacy interventions Workshop: OTC medicines
(facilitator).
57. PSA Refresher Course, Canada, 2004. Pharmacy interventions: Prescription medicines.
58. PSA Refresher Course, Canada, 2004. Pharmacy interventions Workshop: Prescription medicines
(facilitator).
59. PSA Refresher Course, Canada, 2004. Handling S2 sales.
39
60. PSA Refresher Course, Canada, 2004. Connecting professional services to front of shop.
61. Apoteket, Stockholm, 2004. Community pharmacy practice – a patient focussed approach with
business implications.
62. University of Helsinki, Helsinki, 2004. Integrating health policy and research.
63. The Association of Finnish Pharmacists Symposium, Finland, 2004. Value for money – an
Australian case.
64. New Frontiers for Pharmacy – Global Innovation Forum, Toronto, 2003. The Australian
perspective (speaker and panellist).
65. Pharmaceutical Care, Granada, 2003. Importancia relativa de los datos de economía de la salud
para garantizar el pago de los servicios farmacéuticos.
66. Pharmacy World Congress FIP, Sydney, 2003. Dissemination, an important element of the
implementation of a pharmaceutical service.
67. Pharmacy World Congress FIP, Sydney, 2003. A patient focused approach – a pharmacy view.
68. Pharmacy World Congress FIP, Sydney, 2003. Emmerton, L., Benrimoj, S.I., Williams, K.,
Taylor, R., Gadiel, D., Taylor, S., Carroll, P., Gilbert, A., Wolk, J., and Raffaele, C. A conceptual
approach for measurement of clinical benefits associated with pharmacist only and pharmacy
medicines in Australia: work in progress.
69. PSA Refresher Course, Malta, 2003. The provision of pharmacy services through community
pharmacies (keynote speaker).
70. PSA Refresher Course, Malta, 2003. Pharmacists’ future contribution to health care.
71. PSA Refresher Course, Italy, 2003. Professional cognitive services and community pharmacy:
your future business.
72. PSA Refresher Course, Italy, 2003. Clinical interventions for patients obtaining S2 and S3
medications: protect your business.
73. PSA Refresher Course, Italy, 2003. Clinical interventions: expand and differentiate your
dispensing service.
74. PSA Refresher Course, Italy, 2003. Disease state management and its practical application:
develop your professional business.
75. Pharmacy World Congress FIP, France, 2002. Payment, dissemination, and implementation of
professional services (plenary session).
76. 12th International Social Pharmacy Conference, Sydney, 2002. Research and change in pharmacy
practice (plenary session).
77. Australian Pharmaceutical Industry Congress, Bangkok, 2001. Third Guild Government
Agreement – professional and commercial implications (keynote speaker).
78. Pharmacy World Congress FIP, Singapore, 2001. The importance of leadership in the negotiation
for obtaining remuneration (plenary speaker).
79. Denmark Pharmacist’s Association, Denmark, 2001. Pharmaceutical services in community
pharmacy (keynote speaker).
80. Royal Pharmaceutical Society of Great Britain, London, 2001. Overview of pharmacy practice
research.
81. Pharmaceutical Care Foundation, Barcelona, Spain, 2001. Remuneration for pharmaceutical
services (keynote speaker).
82. Pharmacy World Congress FIP, Singapore, 2001. Improve your professional practice with
customers seeking self-care and OTC medications (plenary session speaker).
83. World Self-Medication Industry, Sydney, 2000. Categories for the future (plenary speaker).
84. Pharmacy World Congress FIP, Austria, 2000. New models of pharmacy practice (plenary
speaker).
85. Pharmacy World Congress FIP, Spain, 1999. Value for Pharmacists Forum (plenary speaker).
86. Boots Pharmaceutical, England, 1999. A novel approach for differentiating between effective
and ineffective sore throat medications.
87. Boots Pharmaceutical, England, 1999. Pharmacy practice research: Best practice standards for
community pharmacy.
88. A.P.I. Industry Conference, QE2, New York - Montreal, Oct 1998. Australian Future Health Care
Models: Implications for Community Pharmacy (keynote speaker).
40
89. Pharmacy World Congress FIP, Jerusalem, 1996. Academia and Practice: The Way Forward
(plenary session speaker).
90. Australian Pharmaceutical Industry, Rome, 1996. Future of community pharmacy practice
(keynote speaker).
91. Pharmaceutical Society of Australia, PSA refresher course, Spain, 1994. Lecture series Non-
prescription medications (keynote speaker).
92. Australian Pharmaceutical Industry, Alaska, 1994. Changing the focus from product to
professional services; and work flow changes in community practice (keynote speaker).
93. Pharmaceutical Society of Australia, PSA Refresher Course, Vienna, 1992. Lecture series.
Cough/cold preparations (keynote speaker).
94. Pharmaceutical Society of New Zealand Conference, New Zealand, 1992. Community pharmacy
practice research (keynote speaker).
95. The Institute of Pharmacy Management International 18th Annual Conference, Malta, 1983.
Education for the Practice of the Profession (keynote speaker).
14.2 State and National 1. The Pharmacy Guild of Australia’s Annual National Conference, 2015. Gold Coast, Australia.
Clinical Bites: Stepping Up Your Diabetes Services in Pharmacy.
2. Blackmores Institue Symposium, 2014. Sydney, Australia. Implementing a CM Service in
Community Pharmacy.
3. Pharmacy Australia Congress 2013, Brisbane. Implementation of Diabetes Meds Check.
4. The Pharmacy Guild of Australia’s Annual National Conference 2013, Gold Coast. Building Value
in Diabetes – assisting your patients with blood glucose self-monitoring.
5. Pharmacy Australia Congress 2012, Melbourne. The Great Debate: Pharmacy is an overregulated
profession.
6. Pharmaceutical Society of Australia Pharmacy Live 2012, Sydney. Professional Services in
Community Pharmacy.
7. Pharmacy Australia Congress, 2009. Sydney. Pharmacy in the UK: Building on strength –
Delivering for the future (White Paper), Lessons for Australia. Keynote presentation.
8. Pharmacy Australia Congress, 2009. Sydney .Debate the answer to our future is increasing front
of shop sales not professional services.
9. Roche Pty Ltd, Sydney, New South Wales, October 2006. Future of Community Pharmacy.
10. Pharmacy 2006, Kingscliff, New South Wales, September 2006. Pharmacists Future Contribution
to Health Care (plenary speaker).
11. APP 2006, Gold Coast, Queensland. Management, Implementation, Consistency – delivering the
pharmacy promise: API Plenary: Strategic Planning Pharmacy – the new period of growth starts
today (panel member).
12. APP Conference, Gold Coast, Queensland, March 2005. Lock and load – D day for scheduling is
here.
13. Pharmacy Practice Foundation – Retail Pharmacy Seminar, Sydney, 2004. More Product or New
Front Shop Services (keynote speaker).
14. Australian Pharmacy Professional, Gold Coast, 2004. API Plenary: The Panel – Surviving the
challenges of the next decade (plenary speaker).
15. Pharmacy Australia Congress, Sydney, 2003. How Pharmacy can optimise the value proposition
in Australia.
16. Pharmaceutical Society of Australia Annual Therapeutic Update Weekend, Terrigal, April 2003.
Are you reaping the rewards of professional remuneration? The New Pharmacy Services.
17. APP 2003, Gold Coast, Queensland. Pharmacy’s burden of proof: The change imperative (plenary
speaker).
18. A.P.S.A., Melbourne, December 2002. Overview of new professional services: current and future
opportunities (plenary speaker).
19. Pharmaceutical Society of Australia Continuing Education Conference, Coffs Harbour, November
2002. Pharmacy’s new direction – being paid for professional services.
41
20. Pharmaceutical Society of Australia Continuing Education Conference, Coffs Harbour, November
2002. Consumer medicine information and disease state management.
21. Pharmacy Australia Congress, Hobart, 2002. Future cognitive pharmaceutical services (plenary
speaker).
22. Pharmaceutical Society of Australia Continuing Education Conference, Wollongong, April 2002.
Pharmacy’s new direction – being paid for professional services.
23. Pharmacy Guild of Australia, Sydney, 2002. Risk Manage your S2/S3s (keynote speaker).
24. Community Pharmacy Summit, Gold Coast, 2002. Schedule 2 and Schedule 3 (plenary speaker).
25. Australian Pharmacy Professional, Gold Coast, 2002. Quality care pharmacy project research
support centre (plenary speaker).
26. Australian Pharmacy Professional, Gold Coast, 2001. Payments for professional services
domiciliary medication reviews (plenary speaker).
27. Australian Pharmaceutical Industries Conference, Sydney, 2000. Developments in community
pharmacy.
28. Pharmacy Australia Congress, Sydney, 2000. Role of pharmacy in disease state management
quality use of medicines (keynote speaker).
29. Community Pharmacy Summit (APC), Sydney, 2000. Roles and responsibilities optimising
opportunities: “What services to whom?” (Key note speaker).
30. Australian Pharmacy Professional, Gold Coast, 2000. Quality use of medicines.
31. Pharmacist Advice, NHVPA, Newcastle, 1999. Management Models for Community Pharmacy.
32. Pharmacy Australia Congress, Melbourne, 1999. Practise Change for Profit.
33. Australian Pharmacy Professional, Gold Coast, 1999. Medication Reviews for Ambulatory at Risk
Patients.
34. Australian Pharmacy Professional, Gold Coast, 1999. Medication Reviews for Ambulatory
Patients - Issues and Opportunities.
35. Remote and Isolated Pharmacists Association of Australia Inc. (RIPPA) Annual Conference,
Charles Sturt University, Oct 1999.
36. Australian Pharmaceutical Industry, Sydney, July 1999. Health, pharmaceutical benefits and
implications for community pharmacy and wholesalers.
37. Australian Pharmaceutical Industry, Queensland, 1999. Hypertension - continuing education.
38. Pharmacy Board of New South Wales, 1999. Health, pharmaceutical benefits and implications for
community pharmacy and wholesalers.
39. Pharmacy Australia Congress, Melbourne, 1999. Practice Change for Profit.
40. Australian Pharmacy Professional, Gold Coast, 1998. Forward Pharmacy.
41. Pharmacist Advice, Australian Pharmaceutical Industry Conference, Coffs Harbour, 1997.
42. Australian Pharmacy Professional, Gold Coast, 1997. Medication Management Review - How
will our industry benefit and what steps need to be taken to prepare Community Pharmacists?
43. Illawarra Division of General Practice, Educational Dinner Meeting, 29th April, 1996. The GP and
Pharmacist Interface.
44. Pharmaceutical Society of Australia, Sydney Sutherland Shire, 1994. Pharmacy of the Future.
45. Pharmaceutical Society of Australia, Victoria Branch, Moamma NSW, 1994. Pharmacy Practice -
Cough & Colds.
46. Australian Pharmacy Professional, Gold Coast, 1994. The need for workflow changes within
community pharmacy.
47. Australian Pharmacy Professional, Gold Coast, 1994. Specialisation - providing solutions for
Pharmacy's future?
48. Amcal National Conference, Hamilton Island, 1994. Strategies for the Future.
49. Pharmacy Australia Congress, Sydney, 1994. Pharmacy off The Roundabout - Strategies for the
Future.
50. Pharmacy Australia Congress, Sydney, 1994. Turning Professionalism into Profit.
51. Society of Hospital Pharmacists of Australia National Conference, Sydney. Future Plans for
Postgraduate Pharmacy Education, (1994) 24(1); 55-56.
52. Society of Hospital Pharmacists of Australia National Conference, Sydney. Drug Distribution
Systems; Aust J Hosp Pharm (1994) 24(1):93-94.
42
53. Pharmaceutical Society of Australia, Brisbane, 1992. Satellite Conference. Rational use of
Cough/Cold Preparations.
54. Department of Health and Community Services, Australian National Formulary Conference,
Melbourne, 1992. Australian National Formulary survey.
55. Pharmaceutical Society of Australia, Canberra, 1992. Continuing Education - Schedule 3
medications.
56. University of Sydney, Pharmacy Degree graduation ceremony, February, 1992. Occasional
address. Challenges in Pharmacy Practice.
57. The Proprietary Association of Australia, Canberra, 1988. Consumer Behaviour: results of a study
of consumers' non-prescription medication purchases in pharmacy.
58. Queensland Hypertensive Association, Brisbane, 1987. Hypertension and Non-prescription Drugs.
59. Society for Hospital Pharmacists Association, Lismore Regional Hospital Pharmacist Conference,
Lismore, 1987. Doctor - Pharmacist Communication.
60. Society for Hospital Pharmacists Association, Lismore Regional Hospital Pharmacist Conference,
Lismore, 1986. Computers in Hospital Pharmacy.
61. Mississippi Pharmacists' Association, Oxford, U.S.A., 1985. A Third Class of Drugs.
62. Pharmaceutical Society of Australia, Drugs, Drugs and More Drugs, live-in seminar, Noosa, 1985.
The Poisons Regulations, Counter Prescribing: Theory and Practice.
63. Pharmaceutical Societies of Australia and New Zealand Biennial Conference, Melbourne, 1984.
In Compliance and Counselling.
64. The Institute of Pharmacy Management International 18th Annual Conference, Malta, 1983.
Education for the Practice of the Profession.
65. Pharmacy Guild of Australia (Qld), Day Dream Island, 1982. Pharmacy Education in Qld.
66. Pharmaceutical Society of Australia (Qld), Kooralbyn Valley, 1982. O.T.C. Communication:
Interview Structure and Contents.
67. 51st ANZAAS, Section 6: Pharmaceutical Sciences, Brisbane, 1981. Pre-registration and
Community Practice.
68. Pharmaceutical Society of Australia (Qld), Sunshine Coast, 1981. Patient Counselling and
Communication.
69. Pharmaceutical Society of Australia (Qld), Brisbane, 1981. Management of Professional Services.
70. Pharmaceutical Society of Australia (Qld), Pharmacy Guild of Australia (Qld), Townsville,
1981. Patient Counselling.
15. CONTINUING EDUCATION ARTICLES IN PROFESSIONAL JOURNALS
1. Feletto. E., Wilson. L., Benrimoj, S.I. Managing new ideas and innovation in community
pharmacy AP 2009, 28, 6, 480-482.
2. Feletto. E., Wilson. L., Benrimoj, S.I. Implementing services and creating a flexible pharmacy
(Part 2) AP (2009) 28:12, 1074-1076. **
3. Feletto. E., Wilson. L., Benrimoj, S.I. Implementing services and creating a flexible pharmacy
(Part 1) AP (2009) 28:12, 892-896. **
4. Moles, R., Benrimoj, S.I. Pharmaceutical service provision to NSW private hospitals. A J P
(2000) 81:948. *
5. Peacocke, G., Whitehead, P. Benrimoj, S.I., Kopecny, E., Emerson, L. The best pharmacy practice
for alternative pharmacy arrangements project – part 2: patient medication management services in
coordinated care trials. A J P (2000) 81:777. *
6. Peacocke, G., Whitehead, P. Benrimoj, S.I., Kopecny, E., Emerson, L. The best pharmacy practice
for alternative pharmacy arrangements project – part 1: introduction. A J P (2000) 81:678.*
7. Neto, A., Benrimoj, S.I. Smoking cessation and the training of community pharmacists. A J P
(2000) 81:260.*
8. Ye, M., Williams, K., Benrimoj, S.I. Inappropriate use of non-prescription drugs for primary
dysmenorrhoea A J P (1999) 80(12) 1286.*
9. Moles R., Benrimoj, S.I. Pharmaceutical services to private hospitals. A J P (1999) 80(10) 1066.*
43
10. Gelgor, L., Benrimoj, S.I. Development of a novel method to asses the efficacy of throat lozenges.
A J P (1999) 80(9) 958.*
11. Neto, A.C., Benrimoj, S.I. Information provision and the order effect. A J P (1999) 80(8):861.*
12. Sigrist, T., Benrimoj S.I. Methodology to deal with direct product requests for non-prescription
analgesics. A J P (1999) 80(5):522.*
13. Crampton M., Benrimoj, S.I., Gilbert, A., Quintrell, N.National standards for community
pharmacy: development and evaluation of a national implementation strategy. A J P (1999)
80(4):380.*
14. Kelly, F.S., Benrimoj, S.I. Pharmacy assistant training: expanding knowledge and improving
practice A J P (1999) 80(3):252.*
15. Neto, A.C., Benrimoj, S.I. Non-prescription analgesics: a pharmacy perspective A J P (1999)
80(1):39.*
16. Benrimoj, S.I., Kelly, F. Protocols and training to promote professional OTC service. A J P (1998)
79(9):1067.*
17. Benrimoj, S.I., Langford, J.H., O'Brien, J.A. Switch on to a schedule change. A J P (1998)
79(3):302.*
18. Benrimoj, S.I, Crampton, M., Gilbert A., Quintrell, N. Standards for the provision of pharmacist-
only and pharmacy medicines. A J P (1998) 79(7):820.*
19. Peacocke, G., Whitehead, P., Benrimoj, S.I., Emerson, L. Developing a rural model of pharmacy
practice. A J P (1998) 79(4):435.*
20. Whitehead, P., Peacocke, G., Benrimoj, S.I., Emerson, L. Patient medication management
services in coordinated care trials. A J P (1998) 79(2):177.*
21. Chen, T., Crampton, M., Krass, I., Benrimoj, S.I. Medication regimen review: a national survey. A
J P (1998) 79(1):44.*
22. Aslani, P., Benrimoj, S.I., Krass, I. CMI use by community pharmacists. A J P (1997)
78(12):1380. *
23. Roins, S., Benrimoj, S.I., Carroll, P., Johnson, L. Community pharmacists’ brand recommendation
of non-prescription analgesics for a migraine headache. A J P (1997) 78(7): 766.*
24. Harrison, F., Armour, C.L., Benrimoj, S.I, Krass, I. Disease Management: what does it mean? A J
P (1997) 78(4):398.*
25. Whitehead, P.A., Atkin, P.A., Krass, I., Salole, E.G., Benrimoj, S.I. The financial benefits of
patient drug information. A J P (1997) 78(2):166.*
26. Butcher, M.A., Benrimoj, S.I., Simpson, J. Geriatric patients: who benefits from medication
reviews? A J P (1996) 77 (9):948.*
27. Williams, K.A., Benrimoj, S.I. Pharmacoepidemiological studies of non-prescription products. A
J P (1996) 77:184.*
28. Taylor, S.J., Benrimoj, S.I., Armour, C.L. Prostaglandin E2 gels: how effective is it in practice? A
J P (1996) 77:388.*
29. Roins, S., Benrimoj, S.I., Johnson, L., Carroll, P. Community pharmacists’ recommendation of
non-prescription analgesics. A J P (1996) 77:504.*
30. Chen, T., Casson, C., Krass, I., Benrimoj, S.I. Inter professional communication between
pharmacists and GPs: how often and why do they communicate? A J P (1996) 77:632.*
31. Neto, A., Benrimoj, S.I. Pharmacy-based intervention strategies. A J P (1996) 77:724.*
32. Aslani, P., Krass, I., Benrimoj, S.I. Provision of consumer product information in community
pharmacies. A J P (1996) 76:282. *
33. Williams K.A., Benrimoj, S.I. Risk factors associated with the inappropriate use of non-
prescription non-steroidal anti-inflammatory drugs in primary dysmenorrhoea: preliminary results.
A J P (1996) 26(4):506-507.*
34. Roins, S., Benrimoj, S.I., Carroll, P.R., Johnson, L.W. Use of discrete choice modelling in
determining pharmacists’ brand recommendation of non-prescription analgesics. A J P (1996) 26
(4):507.*
35. Langford, J., Benrimoj, S.I. A comparative clinical trial of topical agents in the prevention of
wound infection. A J P (1996) 26 (4): 508-509.
44
36. Chen, T.F., Casson, C.P., Krass, I., Benrimoj, S.I. Analysis of telephone interactions between
community pharmacists and general medical practitioners: a qualitative study. A J P (1996) 26
(4):513-514.*
37. Casson, C.P., Chen, T.F., Benrimoj, S.I., Krass, I. Attitudes of general practitioners to community
pharmacists’ involvement in the medication regimen review process: a qualitative study. A J P
(1996) 26 (4):513.*
38. Aslani, P., Krass, I., Benrimoj, S.I. A qualitative study of community pharmacists’ attitudes and
behaviours in the use of Consumer Product Information. A J P (1996) 26 (4):513.*
39. McKauge, L., Benrimoj, S.I. Cold Comfort - Update on the common cold. Pharmacy Trade, (June
1994), 30-32. **
40. Robinson, M., Benrimoj, S.I. H2-Receptor Antagonists. Aust. Pharm. (April 1994) 13: 278-285. **
41. Robinson, M., Benrimoj, S.I. Erythromycin group active against range of organisms. Retail
Pharmacy, (April 1994), 4. **
42. Robinson, M., Benrimoj, S.I. Low cholesterol intake vital with gemfibrozil medication. Retail
Pharmacy, (March 1994), 4.**
43. Robinson, M., Benrimoj, S.I. Benzodiazepines: vigil on dependence is essential. Retail Pharmacy,
(February 1994), 4.**
44. Robinson, M., Benrimoj, S.I. Drug therapy for the common cold. Aust. Pharm., (April 1994), 13:
196-204.**
45. Robinson, M., Benrimoj, S.I. Oral contraceptive drugs. Aust. Pharm., (March 1994) 13: 113-
120.**
46. -adrenergic blocking drugs. Aust. Pharm., (Jan/Feb 1994),13: 60-
65.**
47. Benrimoj, S.I. Analysis of the Australian National Formulary Survey. Australian Prescriber 16
(Suppl 3 1993), 21-24.**
48. Robinson, M., Benrimoj, S.I. Regular dosage pattern is part of contraceptive cover. Retail
Pharmacy, (December 1993), 4.**
49. Robinson, M., Benrimoj, S.I. Antidepressant drugs need time to be effective. Retail Pharmacy,
(November 1993), 4.**
50. Robinson, M., Benrimoj, S.I. Calcium blockers suitable if blood pressure, asthma coexist. Retail
Pharmacy, (October 1993), 4.**
51. Robinson, M., Benrimoj, S.I. Tetracycline group is effective against acne. Retail Pharmacy,
(September 1993), 4.**
52. Robinson, M., Benrimoj, S.I. Lithium therapy to counter recurring manic illnesses. Retail
Pharmacy, (August 1993), 4.**
53. Robinson, M., Benrimoj, S.I. Turbuhaler: patient must fully understand the operation. Retail
Pharmacy, (July 1993), 4.**
54. Robinson, M., Benrimoj, S.I. Diet vital to cholesterol lowering drug regimen. Retail Pharmacy,
(June 1993), 4.**
55. Robinson, M., Benrimoj, S.I. Watch potassium levels in hypertension treatment. Retail Pharmacy,
(May 1993), 4. **
56. Robinson, M., Benrimoj, S.I. Ibuprofens: quick pain relief but close monitoring needed. Retail
Pharmacy, (April 1993), 4. **
57. Robinson, M., Benrimoj, S.I. Antibiotics: the course should be completed. Retail Pharmacy,
(March 1993), 4.**
58. Robinson, M., Benrimoj, S.I. Oral hypoglycaemic - a supplement to good diet. Retail Pharmacy,
(February 1993), 4. **
59. Robinson, M., Benrimoj, S.I. Fluoroquinolones: not usually first line therapy. Retail pharmacy
(January 1993), 4. **
60. Meyer, E., Murney, P., Benrimoj, S.I. Schizophrenia. A J P, (Sept 1993), 74: 702-703.**
61. Meyer, E., Murney, P., Benrimoj, S.I. Migraine. A J P., (June 1993), 74: 436-437.**
62. Meyer, E., Murney, P., Benrimoj, S.I. Parkinson's disease. A J P, (April 1993), 74:272-276.**
63. Meyer, E., McKenzie, C.A., Benrimoj, S.I. Epilepsy (Part 3). A J P., (1993), 74:49-50. **
64. Robinson, M., and Benrimoj, S.I. ACE Inhibitors. Aust. Pharm., (December 1993), 12: 746-753.
**
45
65. Robinson, M., Benrimoj, S.I. Systemic Antifungal Drugs. Aust. Pharm., (November, 1993), 12:
676-681.**
66. Robinson, M., Benrimoj, S.I. Diuretic Drugs. Aust. Pharm., (October 1993), 12: 591-599. **
67. Robinson, M., Benrimoj, S.I. Oral Rehydration Therapy. Aust. Pharm., (September 1993), 12:
537-543.**
68. Robinson, M., Benrimoj, S.I. Hormone Replacement Therapy. Aust. Pharm., (August 1993), 12:
471-477.**
69. Robinson, M., Benrimoj, S.I. Antipsychotic Drugs. Aust. Pharm., (July, 1993), 12: 403-409.**
70. Robinson, M., Benrimoj, S.I. Tricyclics and heterocyclic antidepressants. Aust. Pharm., (June
1993), 12: 339-345.**
71. Robinson, M., Benrimoj, S.I. Migraine Therapies. Aust. Pharm., (May 1993), 12: 271-277.**
72. Robinson, M., Benrimoj, S.I. Antihistamines. Aust. Pharm., (April 1993), 12: 201-209.**
73. Robinson, M., Benrimoj, S.I. Cephalosporin antibiotics. Part 2. Aust. Pharm., (March 1993),
12.**
74. Robinson, M., Benrimoj, S.I. Cephalosporin antibiotics. Part 1. Aust. Pharm., (February 1993), 12:
59-64.**
75. Robinson, M., Benrimoj, S.I. Watch tyramine intake while under Moclobemide. Retail
Pharmacy, (December 1992), 4.**
76. Robinson, M., Benrimoj, S.I. An industrial conundrum. Retail Pharmacy, (November 1992), 4.**
77. Robinson, M., Benrimoj, S.I. Take amoxycillin/clavulanic acid with food and water. Retail
Pharmacy, (October 1992), 4. **
78. Robinson, M., Benrimoj, S.I. Anginine: quick to ease in acute angina attacks. Retail Pharmacy,
(September 1992), 4. **
79. Robinson, M., Benrimoj, S.I. Allopurinol treatment is normally long term. Retail Pharmacy,
(August 1992), 4. **
80. Robinson, M., Benrimoj, S.I. Contraceptive changes must be explained. Retail Pharmacy, (July
1992), 4.**
81. Robinson, M., Benrimoj, S.I. Smoking lowers levels of theophylline. Retail Pharmacy, (June
1992), 4.**
82. Robinson, M., Benrimoj, S.I. Lanoxin PG medication usually for life. Retail Pharmacy, (May
1992), 4.**
83. Robinson, M., Benrimoj, S.I. No obvious cause in 75% of epilepsy cases. Retail Pharmacy,
(April 1992), 4.**
84. Robinson, M., Benrimoj, S.I. Patients may react to cephalosporin. Retail Pharmacy, (March
1992), 4. **
85. Robinson, M., Benrimoj, S.I. Treatment must run full course. Retail Pharmacy, (February 1992),
8. **
86. Robinson, M., Benrimoj, S.I. Antidepressant needs time to operate. Retail Pharmacy, (January
1992), 6. **
87. Meyer, E., McKenzie, C.A., Benrimoj, S.I. Epilepsy (Part 2). A J P., (1992), 73:912-913.**
88. Meyer, E., McKenzie, C.A., Benrimoj, S.I. Epilepsy (Part 1). A J P., (1992), 73:743-744. **
89. Robinson, M., Benrimoj, S.I. Topical antifungal agents. Aust. Pharm., (December 1992), 11. **
90. Robinson, M., Benrimoj, S.I. The use and adverse effects of benzodiazepines. Part 2: Adverse
effects. Aust. Pharm., (October 1992), 11. **
91. Robinson, M., Benrimoj, S.I. Calcium channel blockers. Aust. Pharm., (August 1992), 11. **
92. Robinson, M., Benrimoj, S.I. The use and adverse effects of benzodiazepines. Part 1:
Classification and use. Aust. Pharm., (June 1992), 11:180-184. **
93. Robinson, M., Benrimoj, S.I. Adverse effects of non-steroidal anti-inflammatory drugs. Aust.
Pharm., (April 1992), 11. **
94. Robinson, M., Benrimoj, S.I. Nonprescription ophthalmic products. Aust. Pharm., (February
1992), 11:41-50. **
95. Robinson, M., Benrimoj, S.I. The effective healing of ulcers. Retail Pharmacy, (December 1991),
8. **
96. Benrimoj, S.I., Robinson, M., Stewart, K. Watch variety of side-effects from anti-depressants.
Retail Pharmacy, (November 1991), 4. **
46
97. Benrimoj, S.I., Robinson, M., Stewart, K. Renin sensitivity a problem in treatment. Retail
Pharmacy, (October 1991), 17. **
98. Benrimoj, S.I., Robinson, M., Stewart, K. Getting to sleep, with caution. Retail Pharmacy,
(September 1991), 8. **
99. Benrimoj, S.I., Robinson, M., Stewart, K. Peripheral vasodilator therapy. Retail Pharmacy,
(August 1991), 10. **
100. Benrimoj, S.I., Robinson, M., Stewart, K. Counselling can prevent palpitations. Retail Pharmacy,
(July 1991), 19. **
101. Benrimoj, S.I., Robinson, M., Stewart, K. Cutting the workload of the heart. Retail Pharmacy,
(June 1991), 6. **
102. Benrimoj, S.I., Robinson, M., Stewart, K. Diuretics: extra K concern. Retail Pharmacy, (May
1991), 8. **
103. Benrimoj, S.I., Robinson, M., Stewart, K. Advising on asthma management. Pharmacy Trade,
(September 1991), 8. **
104. Benrimoj, S.I., Robinson, M., Stewart, K. Headache cause vital information. Pharmacy Trade,
(June 1991), 12. **
105. Benrimoj, S.I., Robinson, M., Stewart, K. Management of gastric reflux possible with correct
advice. Pharmacy Trade, (April 1991), 18. **
106. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - How to best advise on cough
treatments. Pharmacy Trade, (February 1991), 34. **
107. Robinson, M., Benrimoj, S.I. Quinolone antibiotics. Aust. Pharm., (December 1991), 10:290-297.
**
108. Benrimoj, S.I., Robinson, M. Drugs which lower cholesterol levels. Part 2: A clinical case study.
Aust. Pharm., (October 1991), 10:239-244. **
109. Benrimoj, S.I., Robinson, M., Stewart, K. Drugs which lower cholesterol levels. Part 1: Drug
information. Aust. Pharm., (August 1991), 10:176-184. **
110. Benrimoj, S.I., Robinson, M., Stewart, K. ACE Inhibitors. Part 2: A clinical case study. Aust.
Pharm., (June 1991), 10:130-133. **
111. Benrimoj, S.I., Robinson, M., Stewart, K. ACE Inhibitors. Part 1: Drug information. Aust.
Pharm., (April 1991), 10:88-92. **
112. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - It's giving Gordon the runs.
Your Pharmacy, (December 1990), 13. **
113. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - When a diabetic has a cold.
Your Pharmacy, (November 1990), 16. **
114. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Sore eyes make her see red.
Your Pharmacy, (October 1990), 13. **
115. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - She washed rash right onto her
hands. Your Pharmacy, (September 1990), 20. **
116. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - She wants 'something stronger'.
Your Pharmacy, (August 1990), 11. **
117. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Bill has a burning problem.
Your Pharmacy, (July 1990), 40. **
118. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Stop your bellyaching, Laura.
Your Pharmacy, (June 1990), 18. **
119. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Relieving Rebecca's broken
tooth. Your Pharmacy, (May 1990), 18. **
120. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Puppies need worming more
than people. Your Pharmacy, (April 1990), 26,28. **
121. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - OTC NSAIDs - Their use in
soft tissue injury. Your Pharmacy, (March 1990), 23. **
122. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Managing Jason's sore throat.
Your Pharmacy, (February 1990), 19,32. **
123. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Kim's pain of womanhood.
Your Pharmacy, (November 1989), 14,15. **
47
124. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Better than a poke in the eye.
Your Pharmacy, (October 1989), 29. **
125. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Steroid doesn't have to mean
Arnold Schwarzenegger. Your Pharmacy, (September, 1989), 32,36.
126. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - The sting doesn't pay off for
David. Your Pharmacy, (August 1989), 28,29,34. **
127. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Burn, baby, burn. Your
Pharmacy, (July 1989), 34. **
128. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - The unwanted cap. Your
Pharmacy, (June 1989), 26. **
129. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Easing Stewart's teething
trauma. Your Pharmacy, (May 1989), 20,31.**
130. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - The heartbreak of heartworm.
Your Pharmacy, (April 1989), 18. **
131. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - A bad break in the outfield.
Your Pharmacy, (March 1989), 26-27. **
132. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Cough it up, Neville. Your
Pharmacy, (February 1989), 20-21. **
133. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Avoid a moving violation.
Your Pharmacy, (December 1988), 19. **
134. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Iron for the dieting teenager.
Your Pharmacy, (November 1988), 30-31. **
135. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Pharmacy and the contact lens.
Your Pharmacy, (October 1988), 26-29. **
136. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Beware of home remedies.
Your Pharmacy, (September 1988), 32, 34. **
137. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Making families more
sun-conscious. Your Pharmacy, (August 1988), 31-32. **
138. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Taking rash action. Your
Pharmacy, (July 1988), 34-36. **
139. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - What to do for childhood
coughs? Your Pharmacy, (June 1988), 26-27. **
140. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Worms and the family cat.
Your Pharmacy, (May 1988), 32-34. **
141. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - First aid for the boys. Your
Pharmacy, (April 1988), 22-23. **
142. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Repairs for a weekend warrior.
Your Pharmacy, (March 1988), 34-35. **
143. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Cough of the week. Your
Pharmacy, (February 1988), 20, 21, 26. **
144. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Running on empty. Your
Pharmacy, (December 1987), 12, 23. **
145. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - In your eye. Your Pharmacy,
(October 1987), 21-22. **
146. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - A spot of the sun. Your
Pharmacy, (September 1987), 24-25. **
147. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - The athlete and the foot. Your
Pharmacy, (August 1987), 18. **
148. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - When a runny nose means an
allergy. Your Pharmacy, (July 1987), 21,31. **
149. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Baby's first rash. Your
Pharmacy, (June 1987), 26. **
150. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Worms and their cure. Your
Pharmacy, (May 1987), 16.**
48
151. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - My head is killing me. Your
Pharmacy, (April 1987), 14. **
152. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Mr Richard's upset stomach.
Your Pharmacy, (March 1987), 28. **
153. Benrimoj, S.I., Robinson, M., Stewart, K. A case for counselling - Runny nose. Your Pharmacy,
(February 1986), 1 **
Articles marked with * are one page summaries of research published to inform practitioners of the work
being undertaken.
Articles ** are clinical case studies based on patient requests in community pharmacies or business cases.
They are intended to be used as continuing education material.